cmc10qfiled080709.htm
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
10-Q
x QUARTERLY REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF
THE SECURITIES EXCHANGE ACT OF 1934
For
the quarterly period ended
JUNE
30, 2009
or
o TRANSITION REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE
SECURITIES EXCHANGE ACT OF 1934
For the transition
period from ________ to ________
Commission
File Number 000-30205
CABOT
MICROELECTRONICS CORPORATION
(Exact
name of registrant as specified in its charter)
DELAWARE
|
36-4324765
|
(State
of Incorporation)
|
(I.R.S.
Employer Identification No.)
|
870
NORTH COMMONS DRIVE
|
60504
|
AURORA,
ILLINOIS
|
(Zip
Code)
|
(Address
of principal executive offices)
|
|
Registrant's telephone number,
including area code: (630)
375-6631
Indicate
by check mark whether the registrant (1) has filed all reports required to be
filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the registrant was required
to file such reports), and (2) has been subject to such filing requirements for
the past 90 days.
Indicate
by check mark whether the registrant has submitted electronically and posted on
its corporate Web site, if any, every Interactive Data File required to be
submitted and posted pursuant to Rule 405 of Regulation S-T (Section 232.405 of
this chapter) during the preceding 12 months (or for such shorter period that
the registrant was required to submit and post such files).
Indicate
by check mark whether the registrant is a large accelerated filer, an
accelerated filer, a non-accelerated filer, or a smaller reporting
company. See definitions of “large accelerated filer,” “accelerated
filer” and smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check
one):
Large
accelerated filer
|
X
|
Accelerated
filer
|
|
Non-accelerated
filer
|
|
Smaller
reporting company
|
|
Indicate
by check mark whether the registrant is a shell company (as defined in Rule
12b-2 of the Exchange Act).
As of
July 31, 2009, the Company had 23,428,632 shares of Common Stock, par value
$0.001 per share, outstanding.
CABOT
MICROELECTRONICS CORPORATION
Part
I. Financial Information
|
Page
|
|
|
|
Item
1.
|
|
|
|
|
|
|
|
|
|
Three
and Nine Months Ended June 30, 2009 and 2008
|
3
|
|
|
|
|
|
|
|
June
30, 2009, and September 30, 2008
|
4
|
|
|
|
|
|
|
|
Nine
Months Ended June 30, 2009 and 2008
|
5
|
|
|
|
|
|
6
|
|
|
|
Item
2.
|
|
20
|
|
|
|
Item
3.
|
|
30
|
|
|
|
Item
4.
|
|
31
|
|
|
|
Part
II. Other Information
|
|
|
|
|
Item
1.
|
|
32
|
|
|
|
Item
1A.
|
|
32
|
|
|
|
Item
2.
|
|
37
|
|
|
|
Item
6.
|
|
37
|
|
|
38
|
ITEM
1.
CABOT
MICROELECTRONICS CORPORATION
(Unaudited
and in thousands, except per share amounts)
|
|
Three
Months Ended
|
|
|
Nine
Months Ended
|
|
|
|
June
30,
|
|
|
June
30,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue
|
|
$ |
86,443 |
|
|
$ |
97,047 |
|
|
$ |
194,859 |
|
|
$ |
284,913 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost
of goods sold
|
|
|
46,143 |
|
|
|
51,638 |
|
|
|
113,143 |
|
|
|
152,455 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross
profit
|
|
|
40,300 |
|
|
|
45,409 |
|
|
|
81,716 |
|
|
|
132,458 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating
expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research,
development and technical
|
|
|
10,901 |
|
|
|
12,730 |
|
|
|
35,636 |
|
|
|
36,583 |
|
Selling
and marketing
|
|
|
5,207 |
|
|
|
7,176 |
|
|
|
16,441 |
|
|
|
20,367 |
|
General
and administrative
|
|
|
9,043 |
|
|
|
12,642 |
|
|
|
30,959 |
|
|
|
36,337 |
|
Purchased
in-process research and development
|
|
|
(90 |
) |
|
|
- |
|
|
|
1,410 |
|
|
|
- |
|
Total
operating expenses
|
|
|
25,061 |
|
|
|
32,548 |
|
|
|
84,446 |
|
|
|
93,287 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating
income (loss)
|
|
|
15,239 |
|
|
|
12,861 |
|
|
|
(2,730 |
) |
|
|
39,171 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
income (expense), net
|
|
|
(42 |
) |
|
|
1,239 |
|
|
|
1,311 |
|
|
|
4,563 |
|
Income
(loss) before income taxes
|
|
|
15,197 |
|
|
|
14,100 |
|
|
|
(1,419 |
) |
|
|
43,734 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision
(benefit) for income taxes
|
|
|
6,183 |
|
|
|
4,120 |
|
|
|
(436 |
) |
|
|
13,613 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
income (loss)
|
|
$ |
9,014 |
|
|
$ |
9,980 |
|
|
$ |
(983 |
) |
|
$ |
30,121 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
earnings (loss) per share
|
|
$ |
0.39 |
|
|
$ |
0.43 |
|
|
$ |
(0.04 |
) |
|
$ |
1.29 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
average basic shares outstanding
|
|
|
23,113 |
|
|
|
23,132 |
|
|
|
23,066 |
|
|
|
23,411 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
earnings (loss) per share
|
|
$ |
0.39 |
|
|
$ |
0.43 |
|
|
$ |
(0.04 |
) |
|
$ |
1.28 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
average diluted shares outstanding
|
|
|
23,154 |
|
|
|
23,163 |
|
|
|
23,066 |
|
|
|
23,441 |
|
The
accompanying notes are an integral part of these consolidated financial
statements.
CABOT
MICROELECTRONICS CORPORATION
(Unaudited
and in thousands, except share amounts)
|
|
|
|
|
|
June 30,
2009
|
|
|
September 30, 2008
|
|
ASSETS
|
|
|
|
|
|
|
Current
assets:
|
|
|
|
|
|
|
Cash
and cash equivalents
|
|
$ |
171,237 |
|
|
$ |
221,467 |
|
Short-term
investments
|
|
|
- |
|
|
|
4,950 |
|
Accounts
receivable, less allowance for doubtful accounts of $1,456 at June 30,
2009, and $403 at September 30, 2008
|
|
|
49,218 |
|
|
|
41,630 |
|
Inventories
|
|
|
45,099 |
|
|
|
47,466 |
|
Prepaid
expenses and other current assets
|
|
|
14,139 |
|
|
|
10,714 |
|
Deferred
income taxes
|
|
|
3,994 |
|
|
|
4,365 |
|
Total
current assets
|
|
|
283,687 |
|
|
|
330,592 |
|
|
|
|
|
|
|
|
|
|
Property,
plant and equipment, net
|
|
|
123,738 |
|
|
|
115,843 |
|
Goodwill
|
|
|
38,875 |
|
|
|
7,069 |
|
Other
intangible assets, net
|
|
|
19,021 |
|
|
|
8,712 |
|
Deferred
income taxes
|
|
|
9,745 |
|
|
|
11,178 |
|
Other
long-term assets
|
|
|
15,612 |
|
|
|
4,043 |
|
Total
assets
|
|
$ |
490,678 |
|
|
$ |
477,437 |
|
|
|
|
|
|
|
|
|
|
LIABILITIES
AND STOCKHOLDERS’ EQUITY
|
|
|
|
|
|
|
|
|
Current
liabilities:
|
|
|
|
|
|
|
|
|
Accounts
payable
|
|
$ |
11,469 |
|
|
$ |
13,885 |
|
Capital
lease obligations
|
|
|
1,189 |
|
|
|
1,129 |
|
Accrued
expenses and other current liabilities
|
|
|
15,722 |
|
|
|
22,787 |
|
Total
current liabilities
|
|
|
28,380 |
|
|
|
37,801 |
|
|
|
|
|
|
|
|
|
|
Capital
lease obligations
|
|
|
1,618 |
|
|
|
2,518 |
|
Other
long-term liabilities
|
|
|
10,166 |
|
|
|
2,885 |
|
Total
liabilities
|
|
|
40,164 |
|
|
|
43,204 |
|
|
|
|
|
|
|
|
|
|
Commitments
and contingencies (Note 9)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’
equity:
|
|
|
|
|
|
|
|
|
Common
stock:
|
|
|
|
|
|
|
|
|
Authorized:
200,000,000 shares, $0.001 par value
|
|
|
|
|
|
|
|
|
Issued:
26,108,654 shares at June 30, 2009, and 25,906,990 shares at September 30,
2008
|
|
|
26 |
|
|
|
26 |
|
Capital
in excess of par value of common stock
|
|
|
209,070 |
|
|
|
198,022 |
|
Retained
earnings
|
|
|
322,139 |
|
|
|
323,122 |
|
Accumulated
other comprehensive income
|
|
|
9,606 |
|
|
|
3,054 |
|
Treasury
stock at cost, 2,698,234 shares at June 30, 2009, and 2,683,809 shares at
September 30, 2008
|
|
|
(90,327 |
) |
|
|
(89,991 |
) |
Total
stockholders’ equity
|
|
|
450,514 |
|
|
|
434,233 |
|
|
|
|
|
|
|
|
|
|
Total
liabilities and stockholders’ equity
|
|
$ |
490,678 |
|
|
$ |
477,437 |
|
The
accompanying notes are an integral part of these consolidated financial
statements.
CABOT
MICROELECTRONICS CORPORATION
(Unaudited
and amounts in thousands)
|
|
Nine
Months Ended June 30,
|
|
|
|
|
|
|
|
|
Cash
flows from operating activities:
|
|
|
|
|
|
|
Net
income (loss)
|
|
$ |
(983 |
) |
|
$ |
30,121 |
|
Adjustments
to reconcile net income to net cash provided by operating
activities:
|
|
|
|
|
|
|
|
|
Depreciation
and amortization
|
|
|
18,531 |
|
|
|
19,615 |
|
Share-based
compensation expense
|
|
|
9,956 |
|
|
|
11,339 |
|
Deferred
income tax expense (benefit)
|
|
|
2,200 |
|
|
|
(4,392 |
) |
Provision
for doubtful accounts
|
|
|
1,012 |
|
|
|
(2 |
) |
Non-cash
foreign exchange gain
|
|
|
(1,857 |
) |
|
|
(3,203 |
) |
Loss
on disposal of property, plant and equipment
|
|
|
88 |
|
|
|
564 |
|
Impairment
of property, plant and equipment
|
|
|
1,245 |
|
|
|
4 |
|
Purchased
in-process research and development
|
|
|
1,410 |
|
|
|
- |
|
Other
|
|
|
(3,081 |
) |
|
|
1,317 |
|
Changes
in operating assets and liabilities:
|
|
|
|
|
|
|
|
|
Accounts
receivable
|
|
|
(5,911 |
) |
|
|
2,002 |
|
Inventories
|
|
|
6,865 |
|
|
|
(7,774 |
) |
Prepaid
expenses and other assets
|
|
|
(1,718 |
) |
|
|
(3,659 |
) |
Accounts
payable
|
|
|
(3,568 |
) |
|
|
(3,661 |
) |
Accrued
expenses, income taxes payable and other liabilities
|
|
|
(8,002 |
) |
|
|
417 |
|
Net
cash provided by operating activities
|
|
|
16,187 |
|
|
|
42,688 |
|
|
|
|
|
|
|
|
|
|
Cash
flows from investing activities:
|
|
|
|
|
|
|
|
|
Additions
to property, plant and equipment
|
|
|
(6,990 |
) |
|
|
(15,549 |
) |
Proceeds
from the sale of property, plant and equipment
|
|
|
- |
|
|
|
40 |
|
Acquisition
of business, net of cash acquired
|
|
|
(60,520 |
) |
|
|
- |
|
Purchases
of investments
|
|
|
- |
|
|
|
(233,775 |
) |
Proceeds
from the sale of investments
|
|
|
50 |
|
|
|
371,140 |
|
Net
cash provided by (used in) investing activities
|
|
|
(67,460 |
) |
|
|
121,856 |
|
|
|
|
|
|
|
|
|
|
Cash
flows from financing activities:
|
|
|
|
|
|
|
|
|
Repurchases
of common stock
|
|
|
(336 |
) |
|
|
(34,001 |
) |
Net
proceeds from issuance of stock
|
|
|
1,091 |
|
|
|
1,501 |
|
Principal
payments under capital lease obligations
|
|
|
(840 |
) |
|
|
(800 |
) |
Net
cash used in financing activities
|
|
|
(85 |
) |
|
|
(33,300 |
) |
|
|
|
|
|
|
|
|
|
Effect
of exchange rate changes on cash
|
|
|
1,128 |
|
|
|
1,040 |
|
Increase
(decrease) in cash
|
|
|
(50,230 |
) |
|
|
132,284 |
|
Cash
and cash equivalents at beginning of period
|
|
|
221,467 |
|
|
|
54,557 |
|
Cash
and cash equivalents at end of period
|
|
$ |
171,237 |
|
|
$ |
186,841 |
|
Supplemental
disclosure of non-cash investing and financing activities:
|
|
|
|
|
|
|
Purchases
of property, plant and equipment in accrued liabilities and accounts
payable at the end of the period
|
|
$ |
233 |
|
|
$ |
1,514 |
|
Issuance
of restricted stock
|
|
|
4,209 |
|
|
|
4,850 |
|
Assets
acquired under capital leases
|
|
|
- |
|
|
|
44 |
|
The
accompanying notes are an integral part of these consolidated financial
statements.
CABOT
MICROELECTRONICS CORPORATION
(Unaudited
and in thousands, except share and per share amounts)
1.
BACKGROUND AND BASIS OF PRESENTATION
Cabot Microelectronics Corporation
("Cabot Microelectronics'', "the Company'', "us'', "we'' or "our'') supplies
high-performance polishing slurries and pads used in the manufacture of advanced
integrated circuit (IC) devices within the semiconductor industry, in a process
called chemical mechanical planarization (CMP). CMP polishes surfaces
at an atomic level, thereby enabling IC device manufacturers to produce smaller,
faster and more complex IC devices with fewer defects. We believe we
are the world’s leading supplier of slurries for IC devices. We also
develop, manufacture and sell CMP slurries for polishing certain components in
hard disk drives, specifically rigid disk substrates and magnetic heads, and we
believe we are one of the leading suppliers in this area. In
addition, we develop, produce and sell CMP polishing pads, which are used in
conjunction with slurries in the CMP process. We also pursue a
variety of other demanding surface modification applications outside of the
semiconductor and hard disk drive industries for which our capabilities and
knowledge may provide value in improved surface performance or
productivity. For additional information, refer to Part 1, Item 1,
“Business”, in our annual report on Form 10-K for the fiscal year ended
September 30, 2008.
The unaudited consolidated financial
statements have been prepared by Cabot Microelectronics Corporation pursuant to
the rules of the Securities and Exchange Commission (SEC) and accounting
principles generally accepted in the United States of America. In the
opinion of management, these unaudited consolidated financial statements include
all normal recurring adjustments necessary for the fair presentation of Cabot
Microelectronics’ financial position as of June 30, 2009, cash flows for the
nine months ended June 30, 2009, and June 30, 2008, and results of operations
for the three and nine months ended June 30, 2009, and June 30,
2008. The results of operations for the three and nine months ended
June 30, 2009 may not be indicative of the results to be expected for future
periods, including the fiscal year ending September 30, 2009. These
unaudited consolidated financial statements should be read in conjunction with
the consolidated financial statements and related notes thereto included in
Cabot Microelectronics’ annual report on Form 10-K for the fiscal year ended
September 30, 2008. We currently operate predominantly in one
industry segment - the development, manufacture and sale of CMP
consumables.
The consolidated financial statements
include the accounts of Cabot Microelectronics and its
subsidiaries. All intercompany transactions and balances between the
companies have been eliminated as of June 30, 2009.
2.
BUSINESS COMBINATION
On February 27, 2009, we completed the
acquisition of Epoch Material Co., Ltd. (Epoch), which previously was a
consolidated subsidiary of Eternal Chemical Co., Ltd.
(Eternal). Epoch is a Taiwan-based company specializing in the
development, manufacture and sale of copper CMP slurries and CMP cleaning
solutions to the semiconductor industry, and color filter slurries to the liquid
crystal display (LCD) industry. We paid $59,391 to obtain 90% of
Epoch’s stock, plus $728 of transaction costs, from our available cash
balance. We expect to pay an additional $6,600 to Eternal in August
2010 to acquire the remaining 10% of Epoch’s stock and we have placed $6,600 in
an escrow account in Taiwan to be held for this purpose until the payment
date. The escrow account is recorded as long-term restricted cash at
June 30, 2009 and is included with other long-term assets on our Consolidated
Balance Sheet. During this interim period, Eternal will continue to
hold the remaining 10% ownership interest in Epoch. However, Eternal
has waived rights to any interest in the earnings of Epoch during the interim
period, including any associated dividends. Consequently, we have
recorded a $6,600 long-term liability on our Consolidated Balance Sheet at June
30, 2009 rather than recording a minority interest in Epoch.
CABOT
MICROELECTRONICS CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited
and in thousands, except share and per share amounts)
We account for all business
combinations in accordance with Statement of Financial Accounting Standards No.
141, “Business Combinations” (SFAS 141). Accordingly, the assets and
liabilities of the acquired entity are recorded at their estimated fair values
at the date of acquisition. Goodwill represents the excess of the
purchase price over the fair value of net assets and amounts assigned to
identifiable intangible assets. Purchased in-process research and
development (IPR&D), for which technological feasibility has not yet been
established and no future alternative uses exist, is expensed immediately in
accordance with SFAS 141.
The purchase price for Epoch was
allocated to tangible assets, liabilities assumed, identified intangible assets
acquired, as well as IPR&D, based on our preliminary estimation of their
fair values. The excess of the purchase price over the aggregate fair
values was recorded as goodwill and is generally fully deductible for tax
purposes. The following table summarizes the purchase price
allocation.
|
|
|
|
|
|
|
|
Current
assets
|
|
$ |
11,453 |
|
Long-term
assets
|
|
|
13,965 |
|
In-process
research and development
|
|
|
1,410 |
|
Identified
intangible assets
|
|
|
11,510 |
|
Goodwill
|
|
|
29,877 |
|
Total
assets acquired
|
|
|
68,215 |
|
Total
liabilities assumed
|
|
|
1,496 |
|
Net
assets acquired
|
|
$ |
66,719 |
|
Results of Epoch’s operations from
February 27, 2009, through the end of the third fiscal quarter are included in
our consolidated financial statements.
The following unaudited pro forma
consolidated results of operations have been prepared as if the acquisition of
Epoch had occurred on October 1, 2008 and 2007:
|
|
Three
Months Ended
|
|
|
Nine
Months Ended
|
|
|
|
June
30,
|
|
|
June
30,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
$ |
86,443 |
|
|
$ |
105,656 |
|
|
$ |
199,607 |
|
|
$ |
313,459 |
|
Net
income (loss)
|
|
$ |
8,858 |
|
|
$ |
12,301 |
|
|
$ |
(2,059 |
) |
|
$ |
37,609 |
|
Net
income (loss) per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$ |
0.38 |
|
|
$ |
0.53 |
|
|
$ |
(0.09 |
) |
|
$ |
1.61 |
|
Diluted
|
|
$ |
0.38 |
|
|
$ |
0.53 |
|
|
$ |
(0.09 |
) |
|
$ |
1.60 |
|
The unaudited pro forma consolidated
results of operations do not purport to be indicative of the results that would
have been achieved if the acquisition had actually occurred as of the dates
indicated, or of those results that may be achieved in the
future. The unaudited pro forma consolidated results of operations
include adjustments to net income to give effect to: expensing of IPR&D on
October 1, 2008 and 2007; amortization of intangible assets acquired;
depreciation of property, plant and equipment acquired; and income
taxes.
CABOT
MICROELECTRONICS CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited
and in thousands, except share and per share amounts)
3.
FAIR VALUE OF FINANCIAL INSTRUMENTS
On October 1, 2008, we adopted the
provisions of Statement of Financial Accounting Standards No. 157, “Fair Value
Measurement” (SFAS 157) for all financial assets and financial
liabilities. SFAS 157 establishes a common definition for fair value
in generally accepted accounting principles, establishes a framework for
measuring fair value and expands disclosure about such fair value
measurements. On October 1, 2008, we also adopted FASB Staff Position
(FSP) 157-3, “Determining the Fair Value of a Financial Asset When the Market
for that Asset is Not Active” (FSP 157-3), which clarifies the application of
SFAS 157 in an inactive market and illustrates how an entity would determine
fair value when the market for a financial asset is not active. In
accordance with FSP 157-2, “Effective Date of FASB Statement No. 157” (FSP
157-2), we have not yet adopted the provisions of SFAS 157 that relate to
non-financial assets and non-financial liabilities.
SFAS 157 defines fair value as the
price that would be received from the sale of an asset or paid to transfer a
liability (an exit price) in the principal or most advantageous market for the
asset or liability in an orderly transaction between market participants on the
measurement date. SFAS 157 establishes a three-level hierarchy for
disclosure based on the extent and level of judgment used to estimate fair
value. Level 1 inputs consist of valuations based on quoted market
prices in active markets for identical assets or liabilities. Level 2
inputs consist of valuations based on quoted prices for similar assets or
liabilities, quoted prices for identical assets or liabilities in an inactive
market, or other observable inputs. Level 3 inputs consist of
valuations based on unobservable inputs that are supported by little or no
market activity.
On October 1, 2008, we adopted the
provisions of SFAS No. 159, “The Fair Value Option for Financial Assets and
Financial Liabilities – Including an Amendment of FASB Statement No. 115” (SFAS
159). SFAS 159 allows measurement at fair value of eligible financial
assets and financial liabilities that are not otherwise measured at fair value
on an instrument-by-instrument basis (the “fair value option”). We
did not elect the fair value option for any financial assets or financial
liabilities that were not previously required to be measured at fair
value.
The following table presents financial
assets that we measured at fair value on a recurring basis at June 30,
2009. As permitted under the relevant pronouncements, we have chosen
to not measure any of our financial liabilities at fair value in accordance with
SFAS 157 and SFAS 159 as we believe our financial liabilities approximate their
fair value due to their short-term, highly liquid characteristics. We
have classified these assets in accordance with the fair value hierarchy set
forth in SFAS 157. In instances where the inputs used to measure the
fair value of an asset fall into more than one level of the hierarchy, we have
classified them based on the lowest level input that is significant to the
determination of the fair value.
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
Total
Fair Value
|
|
Cash
and cash equivalents
|
|
$ |
171,237 |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
171,237 |
|
Auction
rate securities (ARS)
|
|
|
- |
|
|
|
- |
|
|
|
8,116 |
|
|
|
8,116 |
|
Total
|
|
$ |
171,237 |
|
|
$ |
- |
|
|
$ |
8,116 |
|
|
$ |
179,353 |
|
Effective April 1, 2009, we adopted the
provisions of FSP FAS 107-1 and APB 28-1, “Interim Disclosures About Fair Value
of Financial Instruments” (FSP 107-1), which amends SFAS No. 107, “Disclosures
About Fair Value of Financial Instruments”, to require disclosures about fair
value of financial instruments in interim reporting periods as well as in annual
financial statements. FSP 107-1 also amends APB Opinion No. 28,
“Interim Financial Reporting”, to require fair value disclosures in summarized
financial information at interim periods. Our cash and cash
equivalents consist of various bank accounts used to support our operations and
investments in institutional money-market funds which are traded in active
markets. The recorded amounts of cash, accounts receivable and
accounts payable approximate their fair values due to their short-term, highly
liquid characteristics. The fair value of our long-term ARS is
determined through a discounted cash flow analysis using a discount rate based
on a market index comprised of tax exempt variable rate demand obligations,
adding a risk factor to reflect current liquidity issues in the ARS
market.
CABOT
MICROELECTRONICS CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited
and in thousands, except share and per share amounts)
Effective April 1, 2009, we adopted the
provisions of FSP FAS 115-2 and FAS 124-2, “Recognition and Presentation of
Other-Than-Temporary Impairments” (FSP 115-2), which amends the
other-than-temporary impairment guidance in U.S. GAAP for debt securities and
improves the presentation and disclosure of other-than-temporary impairments on
debt and equity securities in the financial statements. A debt
security is considered to be impaired when the fair value of a debt security is
less than its amortized cost at the balance sheet date. FSP 115-2
requires the impairment be segregated into amounts relating to credit loss and
amounts relating to all other factors. A credit loss exists when the
present value of the expected cash flows from a security is less than the
amortized cost basis of the security. Under the guidance of FSP
115-2, an impairment is considered to be other-than-temporary when: 1) an entity
intends to sell a debt security that is impaired; 2) when it is more likely than
not that an entity will be required to sell the security before the recovery of
its amortized cost basis; or 3) when a credit loss exists. An entity
must recognize an impairment related to any of the three of these circumstances
currently in earnings.
Effective April 1, 2009, we also
adopted the provisions of FSP FAS 157-4, “Determining Fair Value When the Volume
and Level of Activity for the Asset or Liability Have Significantly Decreased
and Identifying Transactions That Are Not Orderly” (FSP 157-4), which provides
additional guidance for estimating fair value in accordance with SFAS 157 when
market activity has significantly decreased and when transactions in a market
may be distressed. We applied the provisions of FSP 115-2 and FSP
157-4 in the valuation of our ARS at June 30, 2009.
Our ARS investments at June 30, 2009
consisted of two tax exempt municipal debt obligations. We
experienced our first failed auction in February 2008, and since that time the
auctions of our two ARS have continued to fail. Despite the failed
auctions, there have been no defaults of the underlying securities and interest
income on these holdings continues to be received on scheduled interest payment
dates. Our ARS, when purchased, were generally issued by A-rated
municipalities. However, the credit rating of one security (with a par value of
$3,400) was downgraded during our second quarter of fiscal 2008. Both
of our ARS (including the downgraded security) are credit enhanced with bond
insurance to obtain a credit rating of AAA.
Since an active market for ARS does not
currently exist, we determine the fair value of these investments using a Level
3 discounted cash flow analysis and also consider other factors such as the
reduced liquidity in the ARS market and nature of the insurance
backing. Key inputs to our discounted cash flow model included
projected cash flows from interest and principal payments and the weighted
probabilities of future successful auctions or debt refinancing by the
issuer. We also incorporate certain Level 2 market indices into the
discounted cash flow analysis, including published rates such as the LIBOR rate,
the LIBOR Swap Curve and a municipal swap index published by the Securities
Industry and Financial Markets Association.
Based on our fair value assessment, we
determined that one ARS continues to be impaired as of June 30, 2009. This
security has a fair value of $3,166 (par value $3,400) and has been classified
as a long-term asset in Other Long-Term Assets on the Consolidated Balance
Sheet. We assessed the impairment in accordance with the provisions
of FSP 115-2 and determined that the impairment was due to the lack of liquidity
in the ARS market rather than to credit risk. We have maintained the
$234 temporary impairment that we first recorded in fiscal 2008. In
addition, we believe that this ARS is not permanently impaired because in the
event of default by the municipality, the insurance provider would pay interest
and principal following the original repayment schedule and we do not intend to
sell the security nor do we believe we will be required to sell the security
before the value recovers, which may be at maturity. During our
second fiscal quarter ended March 31, 2009, we were able to successfully
monetize at par value $50 of this security as the municipality refinanced a
portion of its debt. We determined that the fair value of the other
ARS was not impaired as of June 30, 2009. See Note 6 for more
information on these investments.
CABOT
MICROELECTRONICS CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited
and in thousands, except share and per share amounts)
4.
INVENTORIES
Inventories consisted of the
following:
|
|
June
30,
|
|
|
September
30,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Raw
materials
|
|
$ |
21,003 |
|
|
$ |
21,378 |
|
Work
in process
|
|
|
3,808 |
|
|
|
4,628 |
|
Finished
goods
|
|
|
20,288 |
|
|
|
21,460 |
|
Total
|
|
$ |
45,099 |
|
|
$ |
47,466 |
|
5.
GOODWILL AND OTHER INTANGIBLE ASSETS
Goodwill was $38,875 as of June 30,
2009, and $7,069 as of September 30, 2008. The increase in goodwill
resulted from the $29,877 of goodwill allocated to the acquisition of Epoch as
discussed in Note 2, plus $1,929 due to foreign exchange fluctuation of the New
Taiwan Dollar related to Epoch.
In accordance with Statement of
Financial Accounting Standards No. 142, “Goodwill and Other Intangible Assets”
(SFAS 142), goodwill and indefinite lived intangible assets are tested for
impairment annually in the fourth fiscal quarter or more frequently if
indicators of potential impairment exist, using a fair-value-based
approach. The recoverability of goodwill and other intangible assets
with indefinite lives is measured at the reporting unit level, which is defined
as either an operating segment or one level below an operating
segment. We have consistently determined the fair value of our
reporting units using a discounted cash flow analysis of our projected future
results. The use of discounted projected future results is based on
assumptions that are consistent with our estimates of future growth within the
strategic plan used to manage the underlying business. Factors
requiring significant judgment include assumptions related to future growth
rates, discount factors and tax rates, among others. Changes in economic and
operating conditions that occur after the annual impairment analysis or an
interim impairment analysis that impact these assumptions may result in future
impairment charges.
We completed our annual impairment test
during our fourth quarter of fiscal 2008 and concluded that no impairment
existed. However, based upon the continued uncertainty in the global
economy, we concluded that sufficient indicators existed to perform an interim
impairment analysis at June 30, 2009 for one of our reporting units that has a
$6,172 carrying value of goodwill and other intangible assets with indefinite
lives. Our impairment analysis at June 30, 2009 included revised
estimates of future revenue and income projections. These projections
are based on management’s view of market and economic data that we use to create
future scenarios. Management combines these data with estimates of
our mix of products sold, production costs and operating expenses. We
discounted the resulting projected cash flows over a range of discount rates
between 11% and 15%, including our weighted average cost of capital as well as
the published cost of capital for a number of our peer companies. We
determined our goodwill and intangible assets with indefinite lives associated
with this reporting unit were not impaired as of June 30, 2009. A
hypothetical 10% decline in our cash flow projections would have resulted in the
calculated fair value of this reporting unit being less than its carrying value
under our projection of a slow economic recovery scenario. This would
have required us to complete additional goodwill impairment testing as defined
in SFAS 142. Due to the ongoing uncertainty in market and economic
conditions, management will continue to monitor and evaluate the carrying value
of goodwill and intangible assets with indefinite lives. We will
perform our annual impairment test during our fourth quarter of fiscal
2009.
CABOT
MICROELECTRONICS CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited
and in thousands, except share and per share amounts)
The
components of other intangible assets are as follows:
|
|
June 30, 2009
|
|
|
September 30, 2008
|
|
|
|
Gross
Carrying
|
|
|
Accumulated
|
|
|
Gross
Carrying
|
|
|
Accumulated
|
|
|
|
Amount
|
|
|
Amortization
|
|
|
Amount
|
|
|
Amortization
|
|
Other intangible assets subject to
amortization:
|
|
|
|
|
|
|
|
|
|
|
|
|
Product
technology
|
|
$ |
8,063 |
|
|
$ |
1,741 |
|
|
$ |
5,380 |
|
|
$ |
1,210 |
|
Acquired
patents and licenses
|
|
|
8,000 |
|
|
|
5,750 |
|
|
|
8,000 |
|
|
|
4,716 |
|
Trade
secrets and know-how
|
|
|
2,550 |
|
|
|
2,550 |
|
|
|
2,550 |
|
|
|
2,550 |
|
Distribution
rights, customer lists and other
|
|
|
11,029 |
|
|
|
1,770 |
|
|
|
1,457 |
|
|
|
1,389 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
other intangible assets subject to amortization
|
|
|
29,642 |
|
|
|
11,811 |
|
|
|
17,387 |
|
|
|
9,865 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
other intangible assets not subject to amortization*
|
|
|
1,190 |
|
|
|
|
|
|
|
1,190 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
other intangible assets
|
|
$ |
30,832 |
|
|
$ |
11,811 |
|
|
$ |
18,577 |
|
|
$ |
9,865 |
|
* Total
other intangible assets not subject to amortization primarily consist of trade
names.
Changes in the amounts recorded as
other intangible assets included $11,510 of intangible assets added as a result
of our acquisition of Epoch and an increase of $745 due to foreign exchange
fluctuation of the New Taiwan Dollar. We acquired $2,520 in product
technology assets with an average useful life of seven years and we acquired
$8,990 of customer lists and other intangible assets with a weighted average
useful life of approximately nine years. We also purchased $1,410 of
IPR&D related to one project. The IPR&D was initially
recorded at $1,500 during the quarter ended March 31, 2009, and adjusted
downward by $90 during the quarter ended June 30, 2009 as purchase accounting
was completed. The amount allocated to IPR&D was determined
through established valuation techniques and was expensed upon acquisition
because technological feasibility had not yet been established and no
alternative future uses existed.
Amortization expense on our other
intangible assets was $597 and $1,936 for the three and nine months ended June
30, 2009, respectively. Amortization expense was $720 and $2,160 for
the three and nine months ended June 30, 2008,
respectively. Estimated future amortization expense for the five
succeeding fiscal years is as follows:
Fiscal Year
|
|
Estimated
Amortization Expense
|
|
Remainder
of 2009
|
|
$ |
586 |
|
2010
|
|
|
2,344 |
|
2011
|
|
|
2,337 |
|
2012
|
|
|
2,337 |
|
2013
|
|
|
2,337 |
|
|
|
|
|
|
CABOT
MICROELECTRONICS CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited
and in thousands, except share and per share amounts)
6.
OTHER LONG-TERM ASSETS
Other long-term assets consisted of the
following:
|
|
June
30,
|
|
|
September
30,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term
investments
|
|
$ |
8,116 |
|
|
$ |
3,216 |
|
Long-term
restricted cash
|
|
|
6,600 |
|
|
|
- |
|
Other
long-term assets
|
|
|
896 |
|
|
|
827 |
|
Total
|
|
$ |
15,612 |
|
|
$ |
4,043 |
|
As discussed in Note 3 of this Form
10-Q, our two ARS that we owned as of June 30, 2009 are classified as long-term
assets. The securities are credit enhanced with bond insurance to a
AAA credit rating and all interest payments continue to be received on a timely
basis. Although we believe these securities will ultimately be
collected in full, we believe that it is not likely that we will be able to
monetize the securities in our next business cycle (which for us is generally
one year). One of these securities with a fair value and par value of
$4,950 had been classified as a short-term investment at September 30,
2008. Since the auctions on this security have continued to fail for
more than one year, we reclassified the $4,950 to other long-term assets on our
Consolidated Balance Sheet during the quarter ended March 31,
2009. We maintained a $234 pretax reduction ($151 net of tax) in fair
value on the other ARS, which is consistent with the fair value reduction as of
September 30, 2008. We assessed the impairment in accordance with the
provisions of FSP 115-2 and determined that the impairment was temporary as it
was related to the illiquid ARS market rather than credit risk. In
addition, we continue to believe this decline in fair value is temporary based
on the nature of the underlying debt, the presence of AAA-rated bond insurance,
our expectation that the issuer may refinance its debt, the fact that all
interest payments have been received, and our intention not to sell the security
nor be required to sell the security until the value recovers, which may be at
maturity, given our current cash position, our expected future cash flow, and
our unused debt capacity.
As discussed in Note 2 of this Form
10-Q, we completed the acquisition of Epoch during the quarter ended March 31,
2009. The terms of this acquisition required us to place $6,600 in an
escrow account representing the cash we expect to pay to Eternal in August 2010
for the remaining 10% ownership interest in Epoch. This cash in
escrow is recorded as long-term restricted cash in Other Long-Term Assets on our
Consolidated Balance Sheet as of June 30, 2009.
7.
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
Accrued expenses and other current
liabilities consisted of the following:
|
|
June
30,
|
|
|
September
30,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accrued
compensation
|
|
$ |
5,997 |
|
|
$ |
16,206 |
|
Goods
and services received, not yet invoiced
|
|
|
4,723 |
|
|
|
2,060 |
|
Warranty
accrual
|
|
|
344 |
|
|
|
863 |
|
Taxes,
other than income taxes
|
|
|
1,124 |
|
|
|
998 |
|
Other
|
|
|
3,534 |
|
|
|
2,660 |
|
Total
|
|
$ |
15,722 |
|
|
$ |
22,787 |
|
The decrease in accrued compensation
resulted primarily from the payment of our annual bonus related to fiscal year
ended September 30, 2008 and a reduction in the bonus accrual for fiscal 2009
compared to the prior fiscal year.
CABOT
MICROELECTRONICS CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited
and in thousands, except share and per share amounts)
8.
DERIVATIVE FINANCIAL INSTRUMENTS
On January 1, 2009, we adopted the
provisions of SFAS No. 161, “Disclosures about Derivative Instruments and
Hedging Activities” (SFAS 161), which requires enhanced disclosures about an
entity’s derivatives and hedging activities. We are required to
provide enhanced disclosures about (a) how and why derivative instruments are
used, (b) how derivative instruments and related hedged items are accounted for
under SFAS No. 133, “Accounting for Derivative Instruments and Hedging
Activities” (SFAS 133) and related interpretations, and (c) how derivative
instruments and related hedged items affect our financial position, financial
performance and cash flows.
Periodically we enter into forward
foreign exchange contracts in an effort to mitigate the risks associated with
currency fluctuations on certain foreign currency balance sheet
exposures. Our foreign exchange contracts do not qualify for hedge
accounting under SFAS No. 133, as amended by SFAS No. 149, “Amendment of
Statement 133 on Instruments and Hedging Activities”, and SFAS No. 52, “Foreign
Currency Translation” (SFAS 52); therefore, the gains and losses resulting from
the impact of currency exchange rate movements on our forward foreign exchange
contracts are recognized as other income or expense in the accompanying
consolidated income statements in the period in which the exchange rates
change. We do not use derivative financial instruments for trading or
speculative purposes. In addition, all derivatives, whether
designated in hedging relationships or not, are required to be recorded on the
balance sheet at fair value. At June 30, 2009, we had one forward
foreign exchange contract selling Japanese Yen related to an intercompany note
with one of our subsidiaries in Japan and for the purpose of hedging the risk
associated with a net transactional exposure in Japanese Yen.
The fair value of our derivative
instrument included in the Consolidated Balance Sheet was as
follows:
|
|
|
Asset Derivatives
|
|
|
Liability Derivatives
|
|
|
Balance
Sheet Location
|
|
Fair
Value at
June
30,
2009
|
|
|
Fair
Value at September 30,
2008
|
|
|
Fair
Value at
June
30,
2009
|
|
|
Fair
Value at September 30,
2008
|
|
Derivatives
not designated as hedging instruments under SFAS 133
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign
exchange contracts
|
Prepaid
expenses and other current assets
|
|
$ |
- |
|
|
$ |
26 |
|
|
$ |
- |
|
|
$ |
- |
|
|
Accrued
expenses and other current liabilities
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
166 |
|
|
$ |
- |
|
The following table summarizes the
effect of our derivative instrument on our Consolidated Statement of Income
(Loss) for the three and nine months ended June 30:
|
|
|
Gain (Loss) Recognized in Statement of Income
(Loss)
|
|
|
|
|
Three Months Ended
|
|
|
Nine Months Ended
|
|
|
Statement
of Income (Loss) Location
|
|
June
30, 2009
|
|
|
June
30, 2008
|
|
|
June
30, 2009
|
|
|
June
30, 2008
|
|
Derivatives
not designated as hedging instruments under SFAS 133
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign
exchange contracts
|
Other
income, net
|
|
$ |
(29 |
) |
|
$ |
2,294 |
|
|
$ |
(2,035 |
) |
|
$ |
(1,779 |
) |
CABOT
MICROELECTRONICS CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited
and in thousands, except share and per share amounts)
9.
CONTINGENCIES
While we are not involved in any legal
proceedings that we believe will have a material impact on our consolidated
financial position, results of operations or cash flows, we periodically become
a party to legal proceedings in the ordinary course of business. For
example, in January 2007, we filed a legal action against DuPont Air Products
NanoMaterials LLC (DA Nano), a CMP slurry competitor, in the United States
District Court for the District of Arizona, charging that DA Nano’s
manufacturing and marketing of CMP slurries infringe five CMP slurry patents
that we own. The affected DA Nano products include certain products
used for tungsten CMP. We filed our infringement complaint as a
counterclaim in response to an action filed by DA Nano in the same court in
December 2006 that seeks declaratory relief and alleges non-infringement,
invalidity and unenforceability regarding some of the patents at issue in our
complaint against DA Nano. DA Nano filed its complaint following our
refusal of its request that we license to it our patents raised in its
complaint. DA Nano’s complaint does not allege any infringement by
our products of intellectual property owned by DA Nano. On July 25,
2008, the District Court issued its patent claim construction, or “Markman”
Order (“Markman Order”) in the litigation. In a Markman ruling, a
district court hearing a patent infringement case interprets and rules on the
scope and meaning of disputed patent claim language regarding the patents in
suit. We believe that a Markman decision is often a significant
factor in the progress and outcome of patent infringement
litigation. In the Markman Order, the District Court adopted
interpretations that we believe are favorable to Cabot Microelectronics on all
claim terms that were in dispute in the litigation. On January 27,
2009, we filed a motion for summary judgment on DA Nano’s infringement of
certain of the patents at issue in the suit, because we believe the evidence
demonstrates that there is no dispute of material fact as to DA Nano’s
infringement of all of these patents with DA Nano’s accused products used for
tungsten CMP. On the same date, DA Nano filed a motion for summary
judgment on non-infringement and invalidity of certain of the patents at issue
in the suit. Although no trial date has been set, prior to the
parties’ filing of their respective summary judgment motions, we had expected
trial in this matter to occur sometime during calendar 2009. However,
the existence of the respective motions for summary judgment is expected to
cause a later trial date. While the outcome of this and any legal matter cannot
be predicted with certainty, we believe that our claims and defenses in the
pending action are meritorious, and we intend to pursue and defend them
vigorously.
Refer to Note 16 of “Notes to the
Consolidated Financial Statements” in Item 8 of Part II of our annual report on
Form 10-K for the fiscal year ended September 30, 2008, for additional
information regarding commitments and contingencies.
PRODUCT
WARRANTIES
We maintain a warranty reserve that
reflects management’s best estimate of the cost to replace product that does not
meet customers’ specifications and performance requirements, and costs related
to such replacement. The warranty reserve is based upon a historical
product replacement rate, adjusted for any specific known conditions or
circumstances. Additions and deductions to the warranty reserve are
recorded in cost of goods sold. Our warranty reserve requirements
changed during the first nine months of fiscal 2009 as follows:
Balance
as of September 30, 2008
|
|
$ |
863 |
|
Reserve
for product warranty during the reporting period
|
|
|
716 |
|
Adjustments
to pre-existing warranty reserve
|
|
|
(758 |
) |
Settlement
of warranty
|
|
|
(477 |
) |
Balance
as of June 30, 2009
|
|
$ |
344 |
|
CABOT
MICROELECTRONICS CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited
and in thousands, except share and per share amounts)
10. SHARE-BASED COMPENSATION
PLANS
We record share-based compensation
expense under the provisions of Statement of Financial Accounting Standards No.
123 (revised 2004), “Share-Based Payment” (SFAS 123R) using the straight-line
approach. We currently issue share-based payments under the following
programs: our Second Amended and Restated Cabot Microelectronics Corporation
2000 Equity Incentive Plan, as amended and restated September 23, 2008 (“2000
Equity Incentive Plan”); our Cabot Microelectronics Corporation Employee Stock
Purchase Plan (ESPP), which was amended to become the Cabot Microelectronics
Corporation 2007 Employee Stock Purchase Plan and approved by our shareholders
on March 4, 2008; and, pursuant to our 2000 Equity Incentive Plan, our
Directors’ Deferred Compensation Plan, as amended September 26, 2006 and our
2001 Executive Officer Deposit Share Program. For additional
information regarding these programs, refer to Note 11 of “Notes to the
Consolidated Financial Statements” included in Item 8 of Part II of our annual
report on Form 10-K for the fiscal year ended September 30, 2008. In
conjunction with certain cost reduction initiatives we implemented in the second
quarter of fiscal 2009, the ESPP was amended to suspend the 15% discount from
the fair market value of our stock that employees previously received on their
ESPP purchases. Pursuant to the amended ESPP, effective with the
six-month period beginning January 1, 2009, the ESPP shares are now purchased at
a price equal to the lower of the closing price at the beginning or end of each
semi-annual offering period.
We record share-based compensation
expense for all of our share-based awards including stock options, restricted
stock, restricted stock units and employee stock purchases. We use
the Black-Scholes model to estimate the grant date fair value of our stock
options and employee stock purchases. This model requires the input
of highly subjective assumptions, including the price volatility of the
underlying stock and the expected term of our stock options. We
estimate the expected volatility of our stock based on a combination of our
stock’s historical volatility and the implied volatilities from actively-traded
options on our stock. We calculate the expected term of our stock
options using the simplified method as discussed in Topic 14 of the Staff
Accounting Bulletin Series, “Share-Based Payment”, due to our limited amount of
historical option exercise data, and we add a slight premium to this expected
term for employees who meet the definition of retirement eligible pursuant to
their grants during the contractual term. The fair value of our
restricted stock and restricted stock unit awards represents the closing price
of our common stock on the date of grant. Share-based compensation
expense related to stock option grants, restricted stock and restricted stock
unit awards is recorded net of expected forfeitures. Our estimated
forfeiture rate is primarily based on historical experience, but may be revised
in future periods if actual forfeitures differ from the estimate.
Share-based compensation expense under
SFAS 123R for the three and nine months ended June 30, 2009, and 2008, was as
follows:
|
|
Three
Months Ended
|
|
|
Nine
Months Ended
|
|
|
|
June
30,
|
|
|
June
30,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost
of goods sold
|
|
$ |
217 |
|
|
$ |
302 |
|
|
$ |
770 |
|
|
$ |
827 |
|
Research,
development and technical
|
|
|
228 |
|
|
|
306 |
|
|
|
850 |
|
|
|
908 |
|
Selling
and marketing
|
|
|
258 |
|
|
|
383 |
|
|
|
952 |
|
|
|
1,116 |
|
General
and administrative
|
|
|
2,123 |
|
|
|
2,909 |
|
|
|
7,384 |
|
|
|
8,488 |
|
Total
share-based compensation expense
|
|
|
2,826 |
|
|
|
3,900 |
|
|
|
9,956 |
|
|
|
11,339 |
|
Tax
benefit
|
|
|
1,010 |
|
|
|
1,389 |
|
|
|
3,557 |
|
|
|
4,039 |
|
Total
share-based compensation expense, net of tax
|
|
$ |
1,816 |
|
|
$ |
2,511 |
|
|
$ |
6,399 |
|
|
$ |
7,300 |
|
For additional information regarding
the estimation of fair value, refer to Note 11 of “Notes to the Consolidated
Financial Statements” included in Item 8 of Part II of our annual report on Form
10-K for the fiscal year ended September 30, 2008.
CABOT
MICROELECTRONICS CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited
and in thousands, except share and per share amounts)
11.
OTHER INCOME (EXPENSE), NET
Other income, net, consisted of the
following:
|
|
Three
Months Ended
|
|
|
Nine
Months Ended
|
|
|
|
June
30,
|
|
|
June
30,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
income
|
|
$ |
106 |
|
|
$ |
996 |
|
|
$ |
996 |
|
|
$ |
4,513 |
|
Interest
expense
|
|
|
(79 |
) |
|
|
(97 |
) |
|
|
(259 |
) |
|
|
(303 |
) |
Other
income (expense)
|
|
|
(69 |
) |
|
|
340 |
|
|
|
574 |
|
|
|
353 |
|
Total
other income (expense), net
|
|
$ |
(42 |
) |
|
$ |
1,239 |
|
|
$ |
1,311 |
|
|
$ |
4,563 |
|
The decrease in interest income during
the three and nine months ended June 30, 2009 was primarily due to lower
interest rates earned on our lower average cash and ARS balances compared to the
same periods in fiscal 2008.
12.
COMPREHENSIVE INCOME
|
The
components of comprehensive income were as
follows:
|
|
|
Three
Months Ended
|
|
|
Nine
Months Ended
|
|
|
|
June
30,
|
|
|
June
30,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
income (loss)
|
|
$ |
9,014 |
|
|
$ |
9,980 |
|
|
$ |
(983 |
) |
|
$ |
30,121 |
|
Other
comprehensive income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
unrealized gain on derivative instruments
|
|
|
8 |
|
|
|
9 |
|
|
|
25 |
|
|
|
27 |
|
Foreign
currency translation adjustment
|
|
|
2,590 |
|
|
|
(2,754 |
) |
|
|
6,487 |
|
|
|
2,608 |
|
Unrealized
gain (loss) on investments
|
|
|
- |
|
|
|
184 |
|
|
|
- |
|
|
|
(151 |
) |
Minimum
pension liability adjustment
|
|
|
13 |
|
|
|
5 |
|
|
|
40 |
|
|
|
14 |
|
Total
comprehensive income
|
|
$ |
11,625 |
|
|
$ |
7,424 |
|
|
$ |
5,569 |
|
|
$ |
32,619 |
|
The foreign currency translation
adjustments during the three and nine months ended June 30, 2009 and 2008
resulted primarily from the changes in the exchange rates of the U.S. dollar
relative to the Japanese Yen.
CABOT
MICROELECTRONICS CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited
and in thousands, except share and per share amounts)
13.
INCOME TAXES
Our effective income tax rate was 40.7%
for the three months ended June 30, 2009 and our effective income tax benefit
rate was 30.7% for the nine months ended June 30, 2009, compared to an effective
income tax rate of 29.2% and 31.1% for the three and nine months ended June 30,
2008, respectively. The effective tax rate during the quarter ended
June 30, 2009 reflects additional expense recognition due to the Company
shifting from a net loss or tax benefit position for the quarter ended March 31,
2009 to a net income or tax expense position for the quarter ended June 30,
2009. The decrease in the effective rate for the nine months ended
June 30, 2009 was primarily due to the reinstatement of the research and
experimentation tax credit in the fourth quarter of fiscal 2008, partially
offset by a decrease in tax-exempt interest income.
During the fiscal quarter ended June
30, 2009, we reduced our liability for uncertain tax positions, as defined by
Financial Interpretation No. 48, by $136 as the federal statute of limitations
relating to our fiscal 2005 tax return had expired. There have been
no other material changes to this liability during the nine months ended June
30, 2009.
14.
EARNINGS (LOSS) PER SHARE
SFAS No. 128, “Earnings per Share”,
requires companies to provide a reconciliation of the numerator and denominator
of the basic and diluted earnings per share computations. Basic and
diluted earnings per share were calculated as follows:
|
|
Three
Months Ended
|
|
|
Nine
Months Ended
|
|
|
|
June
30,
|
|
|
June
30,
|
|
|
|
2009
|
|
|
2008
|
|
|
2009
|
|
|
2008
|
|
Numerator:
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings
(loss) available to common shares
|
|
$ |
9,014 |
|
|
$ |
9,980 |
|
|
$ |
(983 |
) |
|
$ |
30,121 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
average common shares
|
|
|
23,113,062 |
|
|
|
23,131,800 |
|
|
|
23,066,229 |
|
|
|
23,411,038 |
|
(Denominator
for basic calculation)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
average effect of dilutive securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based
compensation
|
|
|
40,931 |
|
|
|
30,890 |
|
|
|
- |
|
|
|
29,488 |
|
Diluted
weighted average common shares
|
|
|
23,153,993 |
|
|
|
23,162,690 |
|
|
|
23,066,229 |
|
|
|
23,440,526 |
|
(Denominator
for diluted calculation)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings
(loss) per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$ |
0.39 |
|
|
$ |
0.43 |
|
|
$ |
(0.04 |
) |
|
$ |
1.29 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
$ |
0.39 |
|
|
$ |
0.43 |
|
|
$ |
(0.04 |
) |
|
$ |
1.28 |
|
For the three months ended June 30,
2009 and 2008, approximately 3.9 million and 2.8 million shares, respectively,
attributable to outstanding stock options were excluded from the calculation of
diluted earnings per share because the exercise price of the options was greater
than the average market price of our common stock and, therefore, their
inclusion would have been anti-dilutive.
For the nine months ended June 30, 2009
and 2008, approximately 3.9 million and 2.7 million shares, respectively,
attributable to outstanding stock options were excluded from the calculation of
diluted earnings per share because the exercise price of the options was greater
than the average market price of our common stock and, therefore, their
inclusion would have been anti-dilutive.
CABOT
MICROELECTRONICS CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited
and in thousands, except share and per share amounts)
15.
NEW ACCOUNTING PRONOUNCEMENTS
In December 2007, the FASB issued SFAS
No. 141 (revised 2007), “Business Combinations” (SFAS 141R), which replaces SFAS
No. 141. The statement retains the purchase method of accounting for
acquisitions, but requires a number of changes, including changes in the way
assets and liabilities are recognized in purchase accounting. It also
changes the recognition of assets acquired and liabilities assumed arising from
contingencies, requires the capitalization of in-process research and
development at fair value, and requires acquisition-related costs to be charged
to expense as incurred. SFAS 141R is effective for us October 1, 2009
and will apply prospectively to business combinations completed on or after that
date.
In December 2007, the FASB issued SFAS
No. 160, “Noncontrolling Interest in Consolidated Financial Statements, an
Amendment of ARB 51” (SFAS 160), which changes the accounting and reporting for
minority equity interests in subsidiaries. Minority interests will be
recharacterized as noncontrolling interests and will be reported as a component
of equity separate from the parent’s equity, and purchases or sales of equity
interests that do not result in a change of control will be accounted for as
equity transactions. In addition, net income attributable to the
noncontrolling interest will be included in consolidated net income on the face
of the statement of operations and, upon loss of control, the interest sold, as
well as any interest retained, will be recorded at fair value with any gain or
loss recognized in earnings. SFAS 160 is effective for us beginning
October 1, 2009 and will apply prospectively, except for the presentation and
disclosure requirements, which will apply retrospectively. We are
currently assessing the potential impact that the adoption of this pronouncement
would have on our results of operations, financial position or cash
flows. Currently, there are no interests in any of our subsidiaries
that are treated as minority interests for accounting purposes. In
conjunction with our acquisition of Epoch from Eternal, Eternal will continue to
hold the remaining 10% ownership interest in Epoch until August
2010. However, Eternal has waived rights to any interest in the
earnings of Epoch during the interim period, including any associated dividends,
so Eternal’s retained ownership is not accounted for as a minority
interest.
In May 2009, the FASB issued SFAS No.
165, “Subsequent Events” (SFAS 165), which establishes general standards of
accounting for and disclosure of events that occur after the balance sheet date
but before financial statements are issued or are available to be
issued. SFAS 165 is effective for interim and annual periods ending
on or after June 15, 2009. We adopted SFAS 165 during the fiscal
quarter ended June 30, 2009 and performed an evaluation of subsequent events
through August 7, 2009, which is the date the financial statements were
issued.
In June 2009, the FASB issued SFAS No.
166, “Accounting for Transfers of Financial Assets – an amendment of FASB
Statement No. 140” (SFAS 166), which prescribes the information that a reporting
entity must provide in its financial reports about the transfer of financial
assets. SFAS 166 amends SFAS No. 140, “Accounting for Transfers and
Servicing of Financial Assets and Extinguishments of Liabilities” (SFAS 140) by
removing the concept of a qualifying special-purpose entity from SFAS 140 and
removes the exception from applying the provisions of Financial Interpretation
No. 46(R) to variable interest entities that are qualifying special-purpose
entities. SFAS 166 is effective for transfers of financial assets
occurring on or after January 1, 2010. We are currently assessing the
potential impact that the adoption of this pronouncement will have on our
results of operations, financial position or cash flows.
In June 2009, the FASB issued SFAS No.
167, “Amendments to FASB Interpretation No. 46(R)” (SFAS 167), which amends FASB
Interpretation No. 46, “Consolidation of Variable Interest Entities (revised
December 2003 – an interpretation of ARB No. 51” (FIN 46(R)) to require an
entity to determine whether its variable interest or interests give it a
controlling financial interest in a variable interest entity
(VIE). SFAS 167 defines the primary beneficiary of a VIE as the
enterprise that has both: 1) the power to direct the activities of a VIE that
most significantly impact the entity’s economic performance; and 2) the
obligation to absorb losses of the entity that could potentially be significant
to the VIE or the right to receive benefits from the entity that could
potentially be significant to the VIE. SFAS 167 also amends FIN 46(R)
to require ongoing reassessments of whether an enterprise is the primary
beneficiary of a VIE. SFAS 167 is effective for annual reporting
periods beginning after November 15, 2009 and for interim reporting periods
within the first annual reporting period. We do not currently have
any interests or arrangements that are considered variable interest
entities.
CABOT
MICROELECTRONICS CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited
and in thousands, except share and per share amounts)
In June 2009, the FASB approved the
“FASB Accounting Standards Codification” (the Codification) as the single source
of authoritative nongovernmental Generally Accepted Accounting Principles (GAAP)
in the United States. The Codification is effective for interim and
annual periods ending after September 15, 2009. In accordance with
the approval of the Codification, the FASB issued SFAS No. 168, “The FASB
Accounting Standards Codification and the Hierarchy of Generally Accepted
Accounting Principles – a replacement of FASB Statement No. 162”, which replaces
SFAS No. 162, “The Hierarchy of Generally Accepted Accounting Principles”, to
establish the Codification as the source of authoritative accounting principles
recognized by the FASB to be applied by nongovernmental entities in preparation
of financial statements in conformity with generally accepted accounting
principles in the United States. SFAS 168 will change the references
we make to accounting literature, but we do not believe the adoption of this
pronouncement will have a material impact on our results of operations,
financial position or cash flows.
The following "Management's Discussion
and Analysis of Financial Condition and Results of Operations", as well as
disclosures included elsewhere in this Form 10-Q, include "forward-looking
statements" within the meaning of the Private Securities Litigation Reform Act
of 1995. This Act provides a safe harbor for forward-looking
statements to encourage companies to provide prospective information about
themselves so long as they identify these statements as forward-looking and
provide meaningful cautionary statements identifying important factors that
could cause actual results to differ from the projected results. All
statements other than statements of historical fact we make in this Form 10-Q
are forward-looking. In particular, the statements herein regarding
future sales and operating results; Company and industry growth, contraction or
trends; growth or contraction of the markets in which the Company participates;
international events or various economic factors; product performance; the
generation, protection and acquisition of intellectual property, and litigation
related to such intellectual property; new product introductions; development of
new products, technologies and markets; the acquisition of or investment in
other entities; uses and investment of the Company’s cash balance; the
construction of facilities by the Company; and statements preceded by, followed
by or that include the words "intends", "estimates", "plans", "believes",
"expects", "anticipates", "should", "could" or similar expressions, are
forward-looking statements. Forward-looking statements reflect our
current expectations and are inherently uncertain. Our actual results
may differ significantly from our expectations. We assume no
obligation to update this forward-looking information. The section
entitled "Risk Factors" describes some, but not all, of the factors that could
cause these differences.
This section, "Management's Discussion
and Analysis of Financial Condition and Results of Operations”, should be read
in conjunction with Cabot Microelectronics’ annual report on Form 10-K for the
fiscal year ended September 30, 2008, including the consolidated financial
statements and related notes thereto.
THIRD
QUARTER OF FISCAL 2009 OVERVIEW
While the global economic recession
continued in our third quarter of fiscal 2009, we believe a combination of
improved underlying demand and inventory replenishment within the semiconductor
industry positively impacted demand for our products during the
quarter. Industry analysts have suggested that this inventory
replenishment is expected to be largely completed by the end of September
2009. We are uncertain as to whether or how long this upturn may
continue as we do not yet have clear evidence of broad-based improvement in end
user demand for electronic goods, which is necessary for sustained long-term
growth for the industry and for our Company. There are many factors
that make it difficult for us to predict future revenue trends for our business,
including: the duration of the global economic downturn and the timing and pace
of a recovery; the cyclical nature of the semiconductor industry; the short
order to delivery time for our products and the associated lack of visibility to
future customer orders; quarter to quarter changes in customer orders regardless
of industry strength; and potential future acquisitions by us.
Revenue for our third quarter of fiscal
2009 was $86.4 million, which represented a decrease of 10.9%, or $10.6 million,
from the third quarter of fiscal 2008 and an increase of 90.4%, or $41.0
million, from the previous fiscal quarter. We believe the decrease in
revenue from fiscal 2008 reflects the adverse impact of the global economic
recession, while the significant increase from last quarter is primarily due to
the improvement in underlying demand and inventory replenishment noted above, as
well as traditional seasonal industry strength.
Gross profit expressed as a percentage
of revenue for our third quarter of fiscal 2009 was 46.6%, and 41.9% on a
year-to-date basis. Gross profit decreased slightly from 46.8%
reported in the third quarter of fiscal 2008 primarily due to a lower-valued
product mix, partially offset by lower fixed manufacturing
costs. Gross profit increased from 28.0% reported in our prior fiscal
quarter primarily due to a significant increase in the utilization of our
manufacturing capacity based on the significant increase in sales from the prior
quarter. Our year-to-date gross profit continues to reflect the
negative impact of the global economic recession and the reduction in demand for
our products that we experienced during the first half of the fiscal
year. We may continue to experience fluctuations in our quarterly
gross profit due to a number of factors, including the extent to which we
utilize our manufacturing capacity and fluctuations in our product
mix.
Operating expenses were $25.1 million
in our third quarter of fiscal 2009, compared to $32.5 million in the third
quarter of fiscal 2008 and $30.0 million in the previous fiscal
quarter. The decrease in operating expenses in the third quarter of
fiscal 2009 from the comparable period of fiscal 2008 was primarily due to lower
staffing related costs and decreased professional fees, including costs to
enforce our intellectual property. The decrease in operating expenses
from the prior quarter was primarily due to the absence of $3.6 million of
specific, pre-tax expenses recorded in our second fiscal quarter, including a
$1.5 million write-off of in-process research and development expenses related
our acquisition of Epoch Material Co., Ltd. (Epoch), a $1.1 million impairment
of certain research and development equipment, and a $1.0 million increase in
our reserve for bad debt expense due to the impact of the global economic
conditions on customer collections. To a lesser extent, the decrease
in operating expenses from the prior quarter was due to lower staffing-related
costs and lower professional fees. The reduction in operating
expenses was also positively impacted by our ongoing cost reduction actions that
we implemented during the first half of fiscal 2009. We currently
expect operating expenses will be at the low end of our previous guidance range
of $115 million to $120 million for full year fiscal 2009, including the
operating expenses of Epoch.
Diluted earnings per share for our
third fiscal quarter was $0.39, a decrease from diluted earnings per share of
$0.43 reported in the third quarter of fiscal 2008, and an increase from the
diluted loss per share of $(0.44) reported in the previous fiscal quarter as a
result of the factors discussed above.
CRITICAL
ACCOUNTING POLICIES AND ESTIMATES AND EFFECTS OF RECENT ACCOUNTING
PRONOUNCEMENTS
We discuss our critical accounting
estimates and effects of recent accounting pronouncements in “Management’s
Discussion and Analysis of Financial Condition and Results of Operations”
included in Item 7 of Part II of our annual report on Form 10-K for the fiscal
year ended September 30, 2008. We believe there have been no material
changes in our critical accounting estimates during the first nine months of
fiscal 2009 except for the determination of our allowance for doubtful accounts
and our analysis of potential impairment of goodwill and intangible
assets. See Notes 3, 8 and 15 of the Notes to the Consolidated
Financial Statements for a discussion of new accounting
pronouncements.
Our allowance for doubtful accounts is
based on historical collection experience, adjusted for any known conditions or
circumstances. The global economic recession has had adverse effects
on our ability to collect accounts receivable from some of our
customers. The recession has also caused two of our customers to file
for bankruptcy or insolvency. We recorded a $1.0 million increase in
our allowance for doubtful accounts during the quarter ended March 31, 2009 to
account for the increased uncertainty in customer collections. We
will continue to closely monitor the financial solvency of our customers and, if
the global economic recession continues, we may have to record additional
increases to our allowance for doubtful accounts.
As discussed in Note 3 of the Notes to
the Consolidated Financial Statements, effective April 1, 2009, we adopted the
provisions of FASB Staff Position (FSP) FAS 115-2 and FAS 124-2, “Recognition
and Presentation of Other-Than-Temporary Impairments” (FSP 115-2), and we
adopted the provisions of FSP FAS 157-4, “Determining Fair Value When the Volume
and Level of Activity for the Asset or Liability Have Significantly Decreased
and Identifying Transactions That Are Not Orderly” (FSP 157-4). FSP
115-2 requires an entity to record an other-than-temporary impairment when a
credit loss exists; that is when the present value of the expected cash flows
from a debt security is less than the amortized cost basis of the
security. Any impairments related to a credit loss are recorded
currently in earnings. FSP 157-4 provides guidance for estimating
fair value when market activity has significantly decreased as is the case in
the current auction rate securities (ARS) market. We have recorded a
temporary impairment of $0.2 million, net of tax, in the value of one of our ARS
in other comprehensive income and we have classified $8.1 million of ARS in
other long-term assets on our Consolidated Balance Sheet as of June 30,
2009. The calculation of fair value and the balance sheet
classification for our ARS requires critical judgments and estimates by
management, including the appropriate discount rate and the probability that a
security may be monetized through a future successful auction or refinancing of
the underlying debt. We performed a discounted cash flow analysis
using a discount rate based on a market index comprised of tax exempt variable
rate demand obligations, and we applied a risk factor to reflect current loss of
liquidity in the ARS market. We then assigned probabilities of
holding each security for less than or equal to one year, five years, and to
maturity to calculate a fair value for each security. The impairment
we have maintained is considered temporary as it relates to the loss of
liquidity in the ARS market.
In accordance with Statement of
Financial Accounting Standards No. 142, “Goodwill and Other Intangible Assets”
(SFAS 142), goodwill and indefinite lived intangible assets are tested for
impairment annually in the fourth fiscal quarter or more frequently if
indicators of potential impairment exist, using a fair-value-based
approach. The recoverability of goodwill and other intangible assets
with indefinite lives is measured at the reporting unit level, which is defined
as either an operating segment or one level below an operating
segment. We have consistently determined the fair value of our
reporting units using a discounted cash flow analysis of our projected future
results. The use of discounted projected future results is based on
assumptions that are consistent with our estimates of future growth within the
strategic plan used to manage the underlying business. Factors
requiring significant judgment include assumptions related to future growth
rates, discount factors and tax rates, among others. Changes in
economic and operating conditions that occur after the annual impairment
analysis or an interim impairment analysis that impact these assumptions may
result in future impairment charges.
We completed our annual impairment test
during our fourth quarter of fiscal 2008 and concluded that no impairment
existed. However, based upon the continued uncertainty in the global
economy, we concluded that sufficient indicators existed to perform another
interim impairment analysis at June 30, 2009 for one of our reporting units that
has a $6.2 million carrying value of goodwill and other intangible assets with
indefinite lives. Our impairment analysis at June 30, 2009 included
revised estimates of future revenue and income projections. These
projections are based on management’s view of market and economic data that we
use to create future scenarios. Management combines this market data
with estimates of our mix of products sold, production costs and operating
expenses. We discounted the resulting projected cash flows over a
range of discount rates between 11% and 15%, including our weighted average cost
of capital as well as the published cost of capital for a number of our peer
companies. We determined our goodwill and intangible assets with
indefinite lives were not impaired as of June 30, 2009. A
hypothetical 10% decline in our cash flow projections would have resulted in the
calculated fair value of this reporting unit being less than its carrying value
under our projection of a slow economic recovery scenario. This would
have required us to complete additional goodwill impairment testing as defined
in SFAS 142. Due to the ongoing uncertainty in market and economic
conditions, management will continue to monitor and evaluate the carrying value
of goodwill and intangible assets with indefinite lives.
RESULTS
OF OPERATIONS
THREE
MONTHS ENDED JUNE 30, 2009, VERSUS THREE MONTHS ENDED JUNE 30, 2008
REVENUE
Revenue was $86.4 million for the three
months ended June 30, 2009, which represented a 10.9%, or $10.6 million,
decrease from the three months ended June 30, 2008. Of this decrease,
$7.1 million was due to a lower priced product mix and $4.8 million was due to
decreased sales volume. These decreases were partially offset by a
$0.9 million benefit due to the effect of foreign exchange rate
changes. We believe the decrease in revenue from fiscal 2008 reflects
the continued impact of the global economic downturn. However, we
experienced an upturn in our business during the third quarter of fiscal 2009
that we believe reflects an improvement in underlying demand as well as a
replenishment of inventory within the semiconductor industry. We are
uncertain as to whether or how long this upturn may continue, as long-term
growth is largely dependent on sustained improvement in the end user demand for
electronic goods, into which we have limited visibility.
COST
OF GOODS SOLD
Total cost of goods sold was $46.1
million for the three months ended June 30, 2009, which represented a decrease
of 10.6%, or $5.5 million, from the three months ended June 30,
2008. The decrease in cost of goods sold was primarily due to $6.2
million from decreased sales volume due to the global economic recession, $3.8
million in lower fixed manufacturing costs and $1.5 million in higher
manufacturing yields, partially offset by a $6.6 million increase due to a
higher-cost product mix.
We implemented a number of cost savings
initiatives during the first half of fiscal 2009. For example, we
shortened work schedules in our manufacturing operations on a global basis to
more closely match production with demand, but we maintained the flexibility to
increase our production levels to meet the increased customer demand for our
products that we experienced during the third quarter of fiscal
2009. A number of other cost savings initiatives remain in effect
including: reduced annual, merit-based salary increases, a modest work force
reduction, a restriction on travel and the suspension of certain employee
benefits, among others. These cost-saving actions are intended to
improve our operating effectiveness during the current economic
recession. We will consider additional cost containment measures as
needed if the soft economic environment continues or worsens.
Fumed metal oxides, such as fumed
silica and fumed alumina, are significant raw materials that we use in many of
our CMP slurries. In an effort to mitigate our risk to rising raw
material costs and to increase supply assurance and quality performance
requirements, we have entered into multi-year supply agreements with a number of
suppliers. For more financial information about our supply contracts,
see “Tabular Disclosure of Contractual Obligations” in this filing as well as in
Item 7 of Part II of our annual report on Form 10-K for the fiscal year ended
September 30, 2008.
Our need for additional quantities or
different kinds of key raw materials in the future has required, and will
continue to require, that we enter into new supply arrangements with third
parties. Future arrangements may result in costs which are different
from those in the existing agreements. In addition, energy costs may
also impact the cost of raw materials, packaging, freight and labor
costs. We also expect to continue to invest in our operations
excellence initiative to improve product quality, reduce variability and improve
product yields in our manufacturing process.
GROSS
PROFIT
Our gross profit as a percentage of
revenue was 46.6% for the three months ended June 30, 2009, as compared to 46.8%
for the three months ended June 30, 2008. The slight decrease was
primarily due to a lower-valued product mix, partially offset by lower fixed
manufacturing costs. We may continue to experience fluctuations in
our quarterly gross profit due to a number of factors, including the factors
mentioned above as well as the extent to which we utilize our manufacturing
capacity.
RESEARCH,
DEVELOPMENT AND TECHNICAL
Total research, development and
technical expenses were $10.9 million for the three months ended June 30, 2009,
which represented a decrease of 14.4%, or $1.8 million, from the three months
ended June 30, 2008. The decrease was primarily due to $1.1 million
in lower staffing-related costs, $0.4 million in lower depreciation and
amortization, and $0.2 million in lower travel-related costs. The
cost reduction initiatives we instituted during the first half of fiscal 2009
helped us achieve these cost savings.
Our research, development and technical
efforts are focused on the following main areas:
·
|
Research
related to fundamental CMP
technology;
|
·
|
Development
and formulation of new and enhanced CMP consumable
products;
|
·
|
Process
development to support rapid and effective commercialization of new
products;
|
·
|
Technical
support of CMP products in our customers’ manufacturing facilities;
and
|
·
|
Evaluation
of new polishing applications outside of the semiconductor
industry.
|
SELLING
AND MARKETING
Selling and marketing expenses were
$5.2 million for the three months ended June 30, 2009, which represented a
decrease of 27.4%, or $2.0 million, from the three months ended June 30,
2008. The decrease was primarily due to $1.1 million in lower
staffing-related costs, $0.4 million in lower travel-related costs, $0.1 million
in lower professional fees and $0.1 million in lower advertising and trade show
costs. Our cost reduction measures that we implemented in the first
half of fiscal 2009 helped us achieve these cost savings.
GENERAL
AND ADMINISTRATIVE
General and administrative expenses
were $9.0 million for the three months ended June 30, 2009, which represented a
decrease of 28.5%, or $3.6 million, from the three months ended June 30,
2008. The decrease
resulted primarily from $1.7 million in lower staffing-related costs, primarily
due to reduced expenses related to our annual bonus plan and share-based
compensation expenses, $1.7 million in lower professional fees, including costs
to enforce our intellectual property, and $0.2 million in lower travel-related
costs.
PURCHASED
IN-PROCESS RESEARCH AND DEVELOPMENT
Purchased in-process research and
development (IPR&D) expense was a credit of $0.1 million for the three
months ended June 30, 2009, resulting from an adjustment to the estimated fair
value of the IPR&D upon completion of the purchase accounting related to the
acquisition of Epoch.
OTHER
INCOME (EXPENSE), NET
Other expense was $0.1 million for the
three months ended June 30, 2009 compared to $1.2 million of other income in the
three months ended June 30, 2008. The decrease in other income was
primarily due to $0.9 million of lower interest income resulting from lower
interest rates on our lower balances of cash and short-term investments, and
$0.4 million in foreign exchange losses. We monetized the majority of
our short-term investments in ARS during fiscal 2008 and reinvested these funds
into money market investments which earn interest at lower rates. See
Note 3 of the Notes to the Consolidated Financial Statements for more
information on our ARS.
PROVISION
FOR INCOME TAXES
Our effective income tax rate was 40.7%
for the three months ended June 30, 2009 compared to a 29.2% effective income
tax rate for the three months ended June 30, 2008. The effective tax
rate during the quarter ended June 30, 2009 reflects additional tax expense
recognition due to the Company moving from a net loss or tax benefit position
for the quarter ended March 31, 2009 to a net income or tax expense position for
the quarter ended June 30, 2009. The increase in the effective rate
in fiscal 2009 also reflects a decrease in tax-exempt interest income from
fiscal 2008 and tax adjustments recorded on the fiscal 2008 tax return filed
during the quarter ended June 30, 2009.
NET
INCOME (LOSS)
Net income was $9.0 million for the
three months ended June 30, 2009, which represented a decrease of 9.7%, or $1.0
million from the three months ended June 30, 2008, as result of the factors
discussed above.
NINE
MONTHS ENDED JUNE 30, 2009, VERSUS NINE MONTHS ENDED JUNE 30, 2008
REVENUE
Revenue was $194.9 million for the nine
months ended June 30, 2009, which represented a 31.6%, or $90.1 million,
decrease from the nine months ended June 30, 2008. Of this decrease,
$92.4 million was due to decreased sales volume driven by the significant
weakening of demand for our products due to the global economic recession that
we experienced during the first half of fiscal 2009, and $1.3 million due to a
lower-priced product mix. These decreases were partially offset by a
$3.4 million increase in revenue due to the effect of foreign exchange rate
changes.
COST
OF GOODS SOLD
Total cost of goods sold was $113.1
million for the nine months ended June 30, 2009, which represented a decrease of
25.8%, or $39.3 million, from the nine months ended June 30, 2008. Of
this decrease, $53.0 million was due to decreased sales volume due to the global
economic recession, $8.6 million was due to lower fixed manufacturing costs and
$4.5 million was due to higher manufacturing yields in our CMP slurry and pad
production. These cost decreases were partially offset by a $12.8
million increase due to a higher-cost product mix, $12.0 million cost increase
due to lower utilization of our manufacturing capacity on the decreased level of
sales and a $2.7 million increase due to the effect of foreign exchange rate
changes.
As discussed above, in response to the
significant decrease in demand for our products due to the global economic
recession, we implemented a number of cost reduction initiatives. A
number of these initiatives remain in effect and are intended to improve our
operating effectiveness during the current economic recession. We
will consider additional cost containment measures as needed if the soft
economic environment continues or worsens.
GROSS
PROFIT
Our gross profit as a percentage of
revenue was 41.9% for the nine months ended June 30, 2009, compared to 46.5% for
the nine months ended June 30, 2008. The decrease was primarily due
to the underutilization of our manufacturing capacity on the significantly lower
level of sales and a higher-cost product mix, partially offset by lower fixed
manufacturing costs and favorable production yields.
RESEARCH,
DEVELOPMENT AND TECHNICAL
Total research, development and
technical expenses were $35.6 million for the nine months ended June 30, 2009,
which represented a decrease of 2.6%, or $0.9 million, from the nine months
ended June 30, 2008. The decrease was primarily related to $1.7
million in lower staffing-related costs, $0.4 million in lower depreciation
expense and $0.3 million in lower travel-related costs. These cost
decreases were partially offset by $1.1 million in pre-tax impairments recorded
during our second quarter of fiscal 2009 on certain research and development
equipment in accordance with SFAS No. 144, “Accounting for the Impairment or
Disposal of Long-Lived Assets” and $0.4 million in higher expenses for
laboratory supplies.
SELLING
AND MARKETING
Selling and marketing expenses were
$16.4 million for the nine months ended June 30, 2009, which represented a
decrease of 19.3%, or $3.9 million, from the nine months ended June 30,
2008. The decrease was primarily due to $2.0 million in lower
staffing-related costs, $0.8 million in lower travel-related costs, $0.3 million
in lower professional fees and $0.3 million in lower advertising and trade show
costs.
GENERAL
AND ADMINISTRATIVE
General and administrative expenses
were $31.0 million for the nine months ended June 30, 2009, which represented a
decrease of 14.8%, or $5.4 million, from the nine months ended June 30,
2008. The decrease
resulted primarily from $3.6 million in lower staffing-related costs, primarily
due to reduced expenses related to our annual bonus plan and lower share-based
compensation expense, and $2.6 million in lower professional fees, including
costs to enforce our intellectual property. These cost savings were
partially offset by a $1.0 million increase in our reserve for bad debt expense
due to the impact of adverse economic conditions on customer collections,
including customer bankruptcies, which we recorded during our second quarter of
fiscal 2009.
PURCHASED
IN-PROCESS RESEARCH AND DEVELOPMENT
Purchased in-process research and
development (IPR&D) expense was $1.4 million for the nine months ended June
30, 2009, resulting from the acquisition of Epoch in the second quarter of
fiscal 2009.
OTHER
INCOME (EXPENSE), NET
Other income was $1.3 million for the
nine months ended June 30, 2009, compared to $4.6 million in the nine months
ended June 30, 2008. The decrease in other income was primarily due
to $3.5 million in lower interest income resulting from lower interest rates on
our lower balances of cash and short-term investments, partially offset by $0.2
million in foreign exchange gains. We monetized the majority of our
short-term investments in ARS during fiscal 2008 and reinvested these funds into
money market investments which generally earn interest at lower
rates. See Note 3 of the Notes to the Consolidated Financial
Statements for more information on our ARS.
PROVISION
FOR INCOME TAXES
Our effective income tax benefit rate
was 30.7% for the nine months ended June 30, 2009 compared to a 31.1% effective
tax rate for the nine months ended June 30, 2008. The change in the
effective tax rate from fiscal 2008 was primarily due to the reinstatement of
the research and experimentation credit in the fourth quarter of fiscal 2008,
partially offset by a decrease in tax-exempt interest income.
NET
INCOME (LOSS)
Net loss was $1.0 million for the nine
months ended June 30, 2009 compared to net income of $30.1 million for the nine
months ended June 30, 2008, as a result of the factors discussed
above.
LIQUIDITY
AND CAPITAL RESOURCES
We generated $16.2 million in cash
flows from operating activities in the first nine months of fiscal 2009,
compared to $42.7 million in cash from operating activities in the first nine
months of fiscal 2008. Our cash provided by operating activities in
the first nine months of fiscal 2009 originated from $29.5 million in non-cash
items partially offset by a net loss of $1.0 million and a $12.3 million
decrease in cash flow due to a net increase in working capital. The
decrease in cash from operations compared to the first nine months of fiscal
2008 was primarily due to decreased net income in the period, the timing of
accounts payable and accrued liability payments, including the payment of our
annual bonus related to fiscal 2008, and increased accounts receivable due to
substantial revenue growth in the third quarter of fiscal 2009, partially offset
by a decrease in inventory levels in fiscal 2009.
In the first nine months of fiscal
2009, cash flows used in investing activities were $67.5 million representing
$60.5 million used for our acquisition of Epoch, net of $6.2 million in cash
acquired, and $7.0 million in purchases of property, plant and
equipment. In the first nine months of fiscal 2008, cash flows
provided by investing activities were $121.9 million. We had net
sales of short-term investments of $137.4 million as we liquidated a majority of
our ARS during the quarter ended March 31, 2008. This cash inflow was
partially offset by $15.5 million in cash used for purchases of property, plant
and equipment, primarily for the purchase and installation of a 300-millimeter
polishing tool and related metrology equipment at our Asia Pacific technology
center and building improvements and equipment to enhance our pad production
capabilities. We estimate that our total capital expenditures in
fiscal 2009 will be approximately $10 million.
In the first nine months of fiscal
2009, cash flows used in financing activities were $0.1 million, representing
$0.8 million in principal payments on capital leases and $0.3 million in
repurchases of common stock pursuant to the terms of our Second Amended and
Restated Cabot Microelectronics Corporation 2000 Equity Incentive Plan for
shares withheld to cover payroll taxes on the vesting of restricted stock
granted under the Equity Incentive Plan, partially offset by $1.1 million
received from the issuance of common stock under our Equity Incentive Plan and
Cabot Microelectronics Corporation 2007 Employee Stock Purchase
Plan. We did not repurchase any shares under our share repurchase
program during the first nine months of fiscal 2009. In the first
nine months of fiscal 2008, cash flows used in financing activities were $33.3
million, primarily as a result of $34.0 million in repurchases of common stock
under our share repurchase program. In January 2008, our Board of
Directors authorized a share repurchase program for up to $75.0 million of our
outstanding common stock. Share repurchases are made from time to
time, depending on market conditions, at management’s discretion. As
of June 30, 2009, we have $50.0 million remaining on this share repurchase
program. We fund share purchases under this program from our
available cash balance. We view this program as a flexible and
effective means to return cash to stockholders.
We have an unsecured revolving credit
facility of $50.0 million with an option to increase the facility up to $80.0
million. Pursuant to an amendment we entered into in October 2008, the agreement
extends to November 2011, with an option to renew for two additional one-year
terms. Under this agreement, interest accrues on any outstanding
balance at either the lending institution’s base rate or the Eurodollar rate
plus an applicable margin. We also pay a non-use fee. This
amendment did not include any other material changes to the terms of the credit
agreement. Loans under this facility are intended primarily for
general corporate purposes, including financing working capital, capital
expenditures and acquisitions. The credit agreement also contains
various covenants. No amounts are currently outstanding under this
credit facility and we believe we are currently in compliance with the
covenants.
As discussed in Note 2 of the Notes to
the Consolidated Financial Statements in this Form 10-Q, we completed our
acquisition of Epoch during our second quarter of fiscal 2009. The total
cash outlay was $60.5 million representing $59.4 million in cash paid to
Epoch’s shareholders on the first closing date of February 27, 2009, $0.7
million in cash paid for transaction costs and $6.6 million held in an escrow
account to be paid to Eternal on the second closing date, in August 2010,
partially offset by $6.2 million in cash acquired with
Epoch.
Despite the ongoing capital and credit
market uncertainty, we believe that our current balance of cash and long-term
investments, cash generated by our operations and available borrowings under our
revolving credit facility will be sufficient to fund our operations, expected
capital expenditures, including merger and acquisition activities, and share
repurchases for the foreseeable future. However, we plan to further
expand our business and continue to improve our technology; therefore, we may
need to raise additional funds in the future through equity or debt financing,
strategic relationships or other arrangements. The current uncertainty in the
capital and credit markets may hinder our ability to secure additional financing
in the type or amount necessary to pursue these objectives.
OFF-BALANCE
SHEET ARRANGEMENTS
At June 30, 2009, and September 30,
2008, we did not have any unconsolidated entities or financial partnerships,
such as entities often referred to as structured finance or special purpose
entities, which might have been established for the purpose of facilitating
off-balance sheet arrangements.
TABULAR
DISCLOSURE OF CONTRACTUAL OBLIGATIONS
The following summarizes our
contractual obligations at June 30, 2009, and the effect such obligations are
expected to have on our liquidity and cash flow in future periods.
CONTRACTUAL
OBLIGATIONS
|
|
|
|
|
Less
Than
|
|
|
1-3
|
|
|
3-5
|
|
|
After
5
|
|
(In
millions)
|
|
Total
|
|
|
1 Year
|
|
|
Years
|
|
|
Years
|
|
|
Years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase
obligations
|
|
$ |
37.9 |
|
|
$ |
35.6 |
|
|
$ |
2.3 |
|
|
$ |
- |
|
|
$ |
- |
|
Acquisition
related
|
|
|
6.6 |
|
|
|
- |
|
|
|
6.6 |
|
|
|
- |
|
|
|
- |
|
Capital
lease obligations
|
|
|
2.8 |
|
|
|
1.2 |
|
|
|
1.6 |
|
|
|
- |
|
|
|
- |
|
Operating
leases
|
|
|
2.8 |
|
|
|
1.2 |
|
|
|
1.6 |
|
|
|
- |
|
|
|
- |
|
Other
long-term liabilities
|
|
|
3.6 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
3.6 |
|
Total
contractual obligations
|
|
$ |
53.7 |
|
|
$ |
38.0 |
|
|
$ |
12.1 |
|
|
$ |
- |
|
|
$ |
3.6 |
|
We operate under a fumed silica supply
agreement with Cabot Corporation under which we are generally obligated to
purchase at least 90% of our six-month volume forecast for certain of our slurry
products, to purchase certain non-material minimum quantities every six months,
and to pay for the shortfall if we purchase less than these
amounts. This agreement was amended in April 2008 to extend the
termination date to December 2012 and to change the pricing and some other
non-material terms of the agreement. The agreement will automatically
renew unless either party gives certain notice of non-renewal. We
currently anticipate we will not have to pay any shortfall under this
agreement. We also operate under a fumed alumina supply agreement
with Cabot Corporation that runs through December 2011, under which we are
obligated to pay certain fixed, capital and variable costs. Purchase
obligations include an aggregate amount of $21.8 million of contractual
commitments for fumed silica and fumed alumina under these
contracts.
As discussed in Note 2 of the Notes to
the Consolidated Financial Statements in this Form 10-Q, we completed the first
closing of our acquisition of Epoch during our second quarter of fiscal
2009. Under the share purchase agreement, we paid $59.4 million to
obtain 90% of Epoch’s stock from Eternal Chemical Co., Ltd.
(Eternal). We expect to pay an additional $6.6 million to Eternal on
the second closing date, in August 2010, and we have placed the $6.6 million in
an escrow account for this purpose to be held until then. The escrow
account is recorded as long-term restricted cash at June 30, 2009 and is
included with other long-term assets on our Consolidated Balance
Sheet. During this interim period, Eternal will continue to hold the
remaining 10% ownership interest in Epoch; however, Eternal has waived rights to
any interest in Epoch earnings during the interim period, including any
associated dividends. Consequently, we have recorded a $6.6 million
long-term liability on our Consolidated Balance Sheet at June 30, 2009 rather
than recording a minority interest in Epoch.
Refer to Item 7
“Management’s Discussion and Analysis of Financial Condition and Results
of Operations” of
Part II of our annual report on Form 10-K for the fiscal year ended
September 30, 2008, for additional information regarding our contractual
obligations.
EFFECT
OF CURRENCY EXCHANGE RATES AND EXCHANGE RATE RISK MANAGEMENT
We conduct business operations outside
of the United States through our foreign operations. Some of our
foreign operations maintain their accounting records in their local
currencies. Consequently, period to period comparability of results
of operations is affected by fluctuations in exchange rates. The
primary currencies to which we have exposure are the Japanese Yen and, to a
lesser extent, the Taiwan Dollar, British Pound and the Euro. From
time to time we enter into forward contracts in an effort to manage foreign
currency exchange exposure. However, we may be unable to hedge these
exposures completely. During the nine months ended June 30, 2009, we
recorded $0.4 million in foreign currency translation gains that are included in
other income on our Consolidated Statement of Income. We also
recorded $6.5 million in currency translation gains, net of tax, that are
included in other comprehensive income on our Consolidated Balance
Sheet. These gains primarily are the result of general weakening of
the U.S. dollar relative to the Japanese Yen. Approximately 22% of
our revenue is transacted in currencies other than the U.S. dollar. We do not
currently enter into forward exchange contracts or other derivative instruments
for speculative or trading purposes.
MARKET
RISK AND SENSITIVITY ANALYSIS RELATED TO FOREIGN EXCHANGE RATE RISK
We have performed a sensitivity
analysis assuming a hypothetical 10% adverse movement in foreign exchange
rates. As of June 30, 2009, the analysis demonstrated that such
market movements would not have a material adverse effect on our consolidated
financial position, results of operations or cash flows over a one-year
period. Actual gains and losses in the future may differ materially
from this analysis based on changes in the timing and amount of foreign currency
rate movements and our actual exposures.
MARKET
RISK RELATED TO INVESTMENTS IN AUCTION RATE SECURITIES
At June 30, 2009, we owned two auction
rate securities (ARS) with a total estimated fair value of $8.1 million ($8.3
million par value) which we classified as other long-term assets on our
Consolidated Balance Sheet. General uncertainties in the global
credit markets caused widespread ARS auction failures as the number of
securities submitted for sale exceeded the number of securities buyers were
willing to purchase. As a result, the short-term liquidity of the ARS
market has been adversely affected.
In the third quarter of fiscal 2009, we
maintained the $0.2 million pre-tax and net of tax reduction that we had
recorded in fiscal 2008 in stockholders’ equity in accumulated other
comprehensive income to reflect a decline in fair value of our ARS which we
believe is temporary as it relates to the loss of liquidity in the ARS market
rather than to credit loss as previously defined in Management’s Discussion and
Analysis of Financial Condition and Results of Operations under the section
titled “Critical Accounting Policies and Estimates and Effects of Recent
Accounting Pronouncements”. We believe that we will be able to
monetize the remaining two securities at par, either through successful
auctions, refinancing of the underlying debt by the issuers, or holding the
securities to maturity. However, if auctions involving our ARS
continue to fail, if issuers are unable to refinance the underlying securities,
if the issuing municipalities are unable to pay debt obligations and the bond
insurance fails, or if credit ratings decline or other adverse developments
occur in the credit markets, then we may not be able to monetize these
securities in the foreseeable future and we may also be required to further
adjust the carrying value of these instruments through an impairment charge that
may be deemed other-than-temporary. See Notes 3 and 6 of the Notes to
the Consolidated Financial Statements and the “Risk Factors” set forth in Part
II, Item 1A of this Quarterly Report on Form 10-Q for more
information.
EVALUATION
OF DISCLOSURE CONTROLS AND PROCEDURES
Our management, with the participation
of our Chief Executive Officer and Chief Financial Officer, has conducted an
evaluation of the effectiveness of the design and operation of our disclosure
controls and procedures (as defined in Rule 13a-15(e) under the Securities
Exchange Act of 1934, as amended) as of the end of the period covered by this
report. Based on that evaluation, our Chief Executive Officer and
Chief Financial Officer have concluded that our disclosure controls and
procedures were effective as of June 30, 2009.
While we believe the present design of
our disclosure controls and procedures is effective enough to make known to our
senior management in a timely fashion all material information concerning our
business, we intend to continue to improve the design and effectiveness of our
disclosure controls and procedures to the extent we believe necessary in the
future to provide our senior management with timely access to such material
information, and to correct deficiencies that we may discover in the future, as
appropriate.
CHANGES
IN INTERNAL CONTROL OVER FINANCIAL REPORTING
The Company acquired Epoch Material
Co., Ltd. (Epoch) in a purchase business combination on February 27,
2009. Consequently, management has excluded Epoch from its assessment
of internal control over financial reporting as of June 30, 2009 and we are
currently in the process of incorporating the internal controls and procedures
of Epoch into our internal control over financial reporting. We will
report on our assessment of our combined operations within the time period
provided by the Sarbanes-Oxley Act of 2002 and the applicable SEC rules and
regulations concerning business combinations. There were no other
changes in our internal control over financial reporting that occurred during
our most recent fiscal quarter that have materially affected, or are reasonably
likely to materially affect, our internal control over financial
reporting.
INHERENT
LIMITATIONS ON EFFECTIVENESS OF CONTROLS
Because of inherent limitations, our
disclosure controls or our internal control over financial reporting may not
prevent all errors and all fraud. A control system, no matter how
well conceived and operated, can provide only reasonable, not absolute,
assurance that the objectives of the control system are met. Further,
the design of a control system must take into account the benefits of controls
relative to their costs. Because of the inherent limitations in all
control systems, no evaluation of controls can provide absolute assurance that
all control issues and instances of fraud, if any, within the Company have been
detected. These inherent limitations include possible faulty judgment
in decision making and breakdowns due to a simple error or
mistake. Additionally, controls can be circumvented by the individual
acts of some persons, by collusion of two or more people or by management
override of the controls. The design of any system of controls also
is based in part upon certain assumptions about the likelihood of future events,
and there can be no assurance that any design will succeed in achieving its
stated goals under all potential future conditions. Over time,
controls may become inadequate because of changes in conditions, or the degree
of compliance with policies or procedures may deteriorate. Because of
the inherent limitations in a cost-effective control system, misstatements due
to error or fraud may occur and not be detected.
PART
II. OTHER INFORMATION
While we are not involved in any legal
proceedings that we believe will have a material impact on our consolidated
financial position, results of operations or cash flows, we periodically become
a party to legal proceedings in the ordinary course of business. For
example, in January 2007, we filed a legal action against DuPont Air Products
NanoMaterials LLC (DA Nano), a CMP slurry competitor, in the United States
District Court for the District of Arizona, charging that DA Nano’s
manufacturing and marketing of CMP slurries infringe five CMP slurry patents
that we own. The affected DA Nano products include certain products
used for tungsten CMP. We filed our infringement complaint as a
counterclaim in response to an action filed by DA Nano in the same court in
December 2006 that seeks declaratory relief and alleges non-infringement,
invalidity and unenforceability regarding some of the patents at issue in our
complaint against DA Nano. DA Nano filed its complaint following our
refusal of its request that we license to it our patents raised in its
complaint. DA Nano’s complaint does not allege any infringement by
our products of intellectual property owned by DA Nano. On July 25,
2008, the District Court issued its patent claim construction, or “Markman”
Order (“Markman Order”) in the litigation. In a Markman ruling, a
district court hearing a patent infringement case interprets and rules on the
scope and meaning of disputed patent claim language regarding the patents in
suit. We believe that a Markman decision is often a significant
factor in the progress and outcome of patent infringement
litigation. In the Markman Order, the District Court adopted
interpretations that we believe are favorable to Cabot Microelectronics on all
claim terms that were in dispute in the litigation. On January 27,
2009, we filed a motion for summary judgment on DA Nano’s infringement of
certain of the patents at issue in the suit, because we believe the evidence
demonstrates that there is no dispute of material fact as to DA Nano’s
infringement of all of these patents with DA Nano’s accused products used for
tungsten CMP. On the same date, DA Nano filed a motion for summary
judgment on non-infringement and invalidity of certain of the patents at issue
in the suit. Although no trial date has been set, prior to the
parties’ filing of their respective motions of summary judgment, we had expected
trial in this matter to occur sometime during calendar 2009. However,
the existence of the respective summary judgment motions for summary judgment is
expected to cause a later trial date. While the outcome of this and
any legal matter cannot be predicted with certainty, we believe that our claims
and defenses in the pending action are meritorious, and we intend to pursue and
defend them vigorously.
We do not believe there have been any
material changes in our risk factors since the filing of our Annual Report on
Form 10-K for the fiscal year ended September 30, 2008 other than the risks
related to worldwide economic and industry conditions as described
below. However, we may update our risk factors in our SEC filings
from time to time for clarification purposes or to include additional
information, at management's discretion, even when there have been no material
changes.
RISKS
RELATING TO OUR BUSINESS
DEMAND
FOR OUR PRODUCTS FLUCTUATES AND OUR BUSINESS MAY BE ADVERSELY AFFECTED BY
WORLDWIDE ECONOMIC AND INDUSTRY CONDITIONS
Our business is affected by economic
and industry conditions and our revenue is dependent upon semiconductor
demand. Semiconductor demand, in turn, is impacted by semiconductor
industry cycles, and these cycles can dramatically affect our
business. These cycles may be characterized by decreases in product
demand, excess customer inventories, and accelerated erosion of
prices. The global economy is currently in recession and we first
began to see significant adverse effects of this in our fourth quarter of fiscal
2008 as the reduction in end user demand for IC devices caused semiconductor
manufacturers to reduce their production, which reduced the demand for our CMP
consumable products. We believe weakness of the U.S. and global
economy and stress in the financial markets have persisted, and this has caused
a significant decrease in demand for our products during the first nine months
of fiscal 2009, as our revenue for that period decreased over 31% from the first
nine months of fiscal 2008. Although demand for our products
increased significantly during our third quarter of fiscal 2009 from the level
achieved during the second quarter, it is uncertain if this increase in demand
will continue. If global economic conditions remain uncertain or
deteriorate further, we may experience additional material adverse impacts on
our results of operations and financial condition.
A prolonged global recession may have
other adverse effects on our Company such as:
·
|
The
ability of our customers to pay their obligations to us may be adversely
affected causing a negative impact on our cash flows and our results of
operations as evidenced by the bankruptcy filing of two of our smaller
customers in the second quarter of fiscal
2009.
|
·
|
The
carrying value of our goodwill and other intangible assets may decline in
value, which could harm our financial position and results of
operations.
|
·
|
Our
suppliers may not be able to fulfill their obligations to us, which could
harm our production process and our
business.
|
Some additional factors that affect
demand for our products include customers’ production of logic versus memory
devices, their transition from 200 mm to 300 mm wafers, customers’ specific
integration schemes, share gains and losses and pricing changes by us and our
competitors.
WE
HAVE A NARROW PRODUCT RANGE AND OUR PRODUCTS MAY BECOME OBSOLETE, OR
TECHNOLOGICAL CHANGES MAY REDUCE OR LIMIT INCREASES IN THE CONSUMPTION OF CMP
SLURRIES AND PADS
Our business is substantially dependent
on a single class of products, CMP slurries, which account for the majority of
our revenue. Our business in CMP pads is also developing and
growing. Our business would suffer if these products became obsolete
or if consumption of these products decreased. Our success depends on
our ability to keep pace with technological changes and advances in the
semiconductor industry and to adapt, improve and customize our products for
advanced IC applications in response to evolving customer needs and industry
trends. Since its inception, the semiconductor industry has
experienced rapid technological changes and advances in the design, manufacture,
performance and application of IC devices, and our customers continually pursue
lower cost of ownership of materials consumed in their manufacturing processes,
including CMP slurries and pads. We expect these technological
changes and advances, and this drive toward lower costs, will continue in the
future. Potential technology developments in the semiconductor
industry, as well as our customers’ efforts to reduce consumption of CMP
slurries and pads and possible reuse or recycling of slurries, could render our
products less important to the IC device manufacturing process.
A
SIGNIFICANT AMOUNT OF OUR BUSINESS COMES FROM A LIMITED NUMBER OF LARGE
CUSTOMERS AND OUR REVENUE AND PROFITS COULD DECREASE SIGNIFICANTLY IF WE LOST
ONE OR MORE OF THESE CUSTOMERS
Our customer base is concentrated among
a limited number of large customers. One or more of these principal
customers could stop buying CMP consumables from us or could substantially
reduce the quantity of CMP consumables they purchase from us. Our
principal customers also hold considerable purchasing power, which can impact
the pricing and terms of sale of our products. Any deferral or
significant reduction in CMP consumables sold to these principal customers, or a
significant number of smaller customers, could seriously harm our business,
financial condition and results of operations.
During the nine months ended June 30,
2009 and 2008, our five largest customers accounted for approximately 41% and
44% of our revenue; respectively. Taiwan Semiconductor Manufacturing
Company (TSMC) was our largest customer during each of these periods, accounting
for approximately 16% and 17% of our revenue for the nine months ended June 30,
2009 and 2008, respectively. In fiscal 2008, our five largest
customers accounted for approximately 44% of our revenue; with TSMC accounting
for approximately 17% of our revenue.
OUR
BUSINESS COULD BE SERIOUSLY HARMED IF OUR COMPETITORS DEVELOP SUPERIOR SLURRY
PRODUCTS, OFFER BETTER PRICING TERMS OR SERVICE, OR OBTAIN CERTAIN INTELLECTUAL
PROPERTY RIGHTS
Competition from other CMP slurry
manufacturers could seriously harm our business and results of
operations. Competition from other providers of CMP slurries could
continue to increase, and opportunities exist for other companies to emerge as
potential competitors by developing their own CMP slurry
products. Increased competition has and may continue to impact the
prices we are able to charge for our slurry products as well as our overall
business. In addition, our competitors could have or obtain
intellectual property rights which could restrict our ability to market our
existing products and/or to innovate and develop new products.
ANY
PROBLEM OR DISRUPTION IN OUR SUPPLY CHAIN, INCLUDING SUPPLY OF OUR MOST
IMPORTANT RAW MATERIALS, OR IN OUR ABILITY TO MANUFACTURE AND DELIVER OUR
PRODUCTS TO OUR CUSTOMERS, COULD ADVERSELY AFFECT OUR RESULTS OF
OPERATIONS
We depend on our supply chain to enable
us to meet the demands of our customers. Our supply chain includes
the raw materials we use to manufacture our products, our production operations,
and the means by which we deliver our products to our customers. Our
business could be adversely affected by any problem or interruption in our
supply of the key raw materials we use in our CMP slurries and pads, including
fumed silica, or any problem or interruption that may occur during production or
delivery of our products, such as weather-related problems or natural
disasters.
For instance, Cabot Corporation
continues to be our primary supplier of particular amounts and types of fumed
silica. We believe it would be difficult to promptly secure
alternative sources of key raw materials, including fumed silica, in the event
one of our suppliers becomes unable to supply us with sufficient quantities of
raw materials that meet the quality and technical specifications required by our
customers. In addition, contractual amendments to the existing
agreements with, or non-performance by, our suppliers, including any significant
financial distress our suppliers may suffer during the current economic
recession, could adversely affect us. Also, if we
change the supplier or type of key raw materials we use to make our CMP slurries
or pads, or are required to purchase them from a different manufacturer or
manufacturing facility or otherwise modify our products, in certain
circumstances our customers might have to requalify our CMP slurries and pads
for their manufacturing processes and products. The requalification
process could take a significant amount of time and expense to complete and
could motivate our customers to consider purchasing products from our
competitors, possibly interrupting or reducing our sales of CMP consumables to
these customers.
WE
ARE SUBJECT TO RISKS ASSOCIATED WITH OUR FOREIGN OPERATIONS
We currently have operations and a
large customer base outside of the United States. Approximately 83%
and 81% of our revenue was generated by sales to customers outside of the United
States for the nine months ended June 30, 2009, and the fiscal year ended
September 30, 2008, respectively. We encounter risks in doing
business in certain foreign countries, including, but not limited to, adverse
changes in economic and political conditions, fluctuation in exchange rates,
compliance with a variety of foreign laws and regulations, as well as difficulty
in enforcing business and customer contracts and agreements, including
protection of intellectual property rights.
WE
MAY PURSUE ACQUISITIONS OF, INVESTMENTS IN, AND STRATEGIC ALLIANCES WITH OTHER
ENTITIES, WHICH COULD DISRUPT OUR OPERATIONS AND HARM OUR OPERATING RESULTS IF
THEY ARE UNSUCCESSFUL
We expect to continue to make
investments in companies, either through acquisitions, investments or alliances,
in order to supplement our internal growth and development
efforts. Acquisitions and investments, including our acquisition of
Epoch Material Co., Ltd., a Taiwan-based company, the first closing of which we
completed in the fiscal quarter ended March 31, 2009, involve numerous risks,
including the following: difficulties in integrating the operations,
technologies, products and personnel of acquired companies; diversion of
management’s attention from normal daily operations of the business; increased
risk associated with foreign operations; potential difficulties in entering
markets in which we have limited or no direct prior experience and where
competitors in such markets have stronger market positions; potential
difficulties in operating new businesses with different business models;
potential difficulties with regulatory or contract compliance in areas in which
we have limited experience; initial dependence on unfamiliar supply chains or
relatively small supply partners; insufficient revenues to offset increased
expenses associated with acquisitions; potential loss of key employees of the
acquired companies; or inability to effectively cooperate and collaborate with
our alliance partners.
Further, we may never realize the
perceived or anticipated benefits of a business combination or investments in
other entities. Acquisitions by us could have negative effects on our
results of operations, in areas such as contingent liabilities, gross profit
margins, amortization charges related to intangible assets and other effects of
accounting for the purchases of other business entities. Investments
in and acquisitions of technology-related companies are inherently risky because
these businesses may never develop, and we may incur losses related to these
investments. In addition, we may be required to write down the
carrying value of acquisitions or investments to reflect other than temporary
declines in their value, which could harm our business and results of
operations.
BECAUSE
WE HAVE LIMITED EXPERIENCE IN BUSINESS AREAS OUTSIDE OF CMP SLURRIES, EXPANSION
OF OUR BUSINESS INTO NEW PRODUCTS AND APPLICATIONS MAY NOT BE
SUCCESSFUL
An element of our strategy has been to
leverage our current customer relationships and technological expertise to
expand our CMP business from CMP slurries into other areas, such as CMP
polishing pads. Additionally, pursuant to our Engineered Surface
Finishes business, we are pursuing a number of surface modification
applications, such as high precision optics. Expanding our business
into new product areas could involve technologies, production processes and
business models in which we have limited experience, and we may not be able to
develop and produce products or provide services that satisfy customers’ needs
or we may be unable to keep pace with technological or other
developments. Also, our competitors may have or obtain intellectual
property rights which could restrict our ability to market our existing products
and/or to innovate and develop new products.
BECAUSE
WE RELY HEAVILY ON OUR INTELLECTUAL PROPERTY, OUR FAILURE TO ADEQUATELY OBTAIN
OR PROTECT IT COULD SERIOUSLY HARM OUR BUSINESS
Protection of intellectual property is
particularly important in our industry because we develop complex technical
formulas for CMP products that are proprietary in nature and differentiate our
products from those of our competitors. Our intellectual property is
important to our success and ability to compete. We attempt to
protect our intellectual property rights through a combination of patent,
trademark, copyright and trade secret laws, as well as employee and third-party
nondisclosure and assignment agreements. Due to our international
operations, we pursue protection in different jurisdictions, which may provide
varying degrees of protection, and we cannot provide assurance that we can
obtain adequate protection in each such jurisdiction. Our failure to
obtain or maintain adequate protection of our intellectual property rights for
any reason, including through the patent prosecution process or in the event of
litigation related to such intellectual property, such as the current litigation
between us and DuPont Air Products Nanomaterials described in “Legal
Proceedings” in this Form 10-Q, could seriously harm our business. In
addition, the costs of obtaining or protecting our intellectual property could
negatively affect our operating results.
WE
MAY NOT BE ABLE TO MONETIZE OUR INVESTMENTS IN AUCTION RATE SECURITIES IN THE
SHORT TERM AND WE COULD EXPERIENCE A DECLINE IN THEIR MARKET VALUE, WHICH COULD
ADVERSELY AFFECT OUR FINANCIAL RESULTS
We owned auction rate securities (ARS)
with an estimated fair value of $8.1 million ($8.3 million par value) at June
30, 2009. We classified these investments as Other Long-Term Assets
on our Consolidated Balance Sheet as of June 30, 2009. If auctions
involving our ARS continue to fail, if issuers of our ARS are unable to
refinance the underlying securities, if issuers are unable to pay debt
obligations and related bond insurance fails, or if credit ratings decline or
other adverse developments occur in the credit markets, then we may not be able
to monetize these securities in the foreseeable future. We may also
be required to further adjust the carrying value of these instruments through an
impairment charge that may be deemed other-than-temporary which would adversely
affect our financial results.
OUR
INABILITY TO ATTRACT AND RETAIN KEY PERSONNEL COULD CAUSE OUR BUSINESS TO
SUFFER
If we fail to attract and retain the
necessary managerial, technical and customer support personnel, our business and
our ability to maintain existing and obtain new customers, develop new products
and provide acceptable levels of customer service could suffer. We
compete with other industry participants for qualified personnel, particularly
those with significant experience in the semiconductor industry. The
loss of services of key employees could harm our business and results of
operations.
RISKS
RELATING TO THE MARKET FOR OUR COMMON STOCK
THE
MARKET PRICE MAY FLUCTUATE SIGNIFICANTLY AND RAPIDLY
The market price of our common stock
has fluctuated and could continue to fluctuate significantly as a result of
factors such as: economic and stock market conditions generally and specifically
as they may impact participants in the semiconductor and related industries;
changes in financial estimates and recommendations by securities analysts who
follow our stock; earnings and other announcements by, and changes in market
evaluations of, us or participants in the semiconductor and related industries;
changes in business or regulatory conditions affecting us or participants in the
semiconductor and related industries; announcements or implementation by us, our
competitors, or our customers of technological innovations, new products or
different business strategies; and trading volume of our common
stock.
ANTI-TAKEOVER
PROVISIONS UNDER OUR CERTIFICATE OF INCORPORATION AND BYLAWS AND OUR RIGHTS PLAN
MAY DISCOURAGE THIRD PARTIES FROM MAKING AN UNSOLICITED BID FOR OUR
COMPANY
Our certificate of incorporation, our
bylaws, our rights plan and various provisions of the Delaware General
Corporation Law may make it more difficult to effect a change in control of our
Company. For example, our amended and restated certificate of
incorporation authorizes our Board of Directors to issue up to 20 million shares
of blank check preferred stock and to attach special rights and preferences to
this preferred stock, which may make it more difficult or expensive for another
person or entity to acquire control of us without the consent of our Board of
Directors. Also our amended and restated certificate of incorporation
provides for the division of our Board of Directors into three classes as nearly
equal in size as possible with staggered three-year terms.
We have adopted change in control
arrangements covering our executive officers and other key
employees. These arrangements provide for a cash severance payment,
continued medical benefits and other ancillary payments and benefits upon
termination of service of a covered employee’s employment following a change in
control, which may make it more expensive to acquire our Company.
ISSUER
PURCHASES OF EQUITY SECURITIES
Period
|
|
Total
Number of Shares Purchased
|
|
Average
Price Paid Per Share
|
|
Total
Number of Shares Purchased as Part of Publicly Announced Plans or
Programs
|
|
Approximate
Dollar Value of Shares that May Yet Be Purchased Under the Plans or
Programs (in thousands)
|
Apr.
1 through
Apr.
30, 2009
|
|
74
|
|
$24.52
|
|
-
|
|
$50,003
|
May
1 through
May
31, 2009
|
|
-
|
|
-
|
|
-
|
|
$50,003
|
Jun.
1 through
Jun.
30, 2009
|
|
-
|
|
-
|
|
-
|
|
$50,003
|
Total
|
|
74
|
|
$24.52
|
|
-
|
|
$50,003
|
In January 2008, we announced that the
Board of Directors had authorized a share repurchase program for up to $75.0
million of our outstanding common stock. Shares are repurchased from
time to time, depending on market conditions, in open market transactions, at
management’s discretion. We fund share repurchases from our existing
cash balance. The program, which became effective on the
authorization date, may be suspended or terminated at any time, at the Company’s
discretion. We view the program as a flexible and effective means to
return cash to stockholders. No shares were repurchased under this
program during the fiscal quarter ended June 30, 2009.
Separate from this share repurchase
program, the shares purchased during the third quarter of fiscal 2009 were
purchased pursuant to the terms of our Second Amended and Restated Cabot
Microelectronics Corporation 2000 Equity Incentive Plan as shares withheld from
award recipients to cover payroll taxes on the vesting of shares of restricted
stock granted under the Equity Incentive Plan.
|
The
exhibit numbers in the following list correspond to the number assigned to
such exhibits in the Exhibit Table of Item 601 of Regulation
S-K:
|
Exhibit
Number
|
Description
|
10.57
|
Adoption
agreement, as amended April 1, 2009, of Cabot Microelectronics Corporation
401(k) Plan.
|
|
|
31.1
|
Certification
of Chief Executive Officer pursuant to Rule 13a-14(a) and 15d-14(a) of the
Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
|
|
|
31.2
|
Certification
of Chief Financial Officer pursuant to Rule 13a-14(a) and 15d-14(a) of the
Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
|
|
|
32.1
|
Certification
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002.
|
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
|
CABOT
MICROELECTRONICS CORPORATION
|
|
|
|
|
Date:
August 7, 2009
|
/s/ WILLIAM S. JOHNSON
|
|
William
S. Johnson
|
|
Vice
President and Chief Financial Officer
|
|
[Principal
Financial Officer]
|
|
|
|
|
Date:
August 7, 2009
|
/s/ THOMAS S. ROMAN
|
|
Thomas
S. Roman
|
|
Corporate
Controller
|
|
[Principal
Accounting Officer]
|
38